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The emerging lipidomics field can be used to understand key differences in the 
phospholipid composition of human pathogens such as the malaria-causing 
parasites of the genus Plasmodium. While rapid advances in the technology used 
for high-throughput analyses have decreased the cost and time needed for 
lipidomics data generation, the interpretation of these large data sets has become 
a significant bottleneck. In this thesis we present the first lipidomics analysis of 
Plasmodium vivax (the most important cause of malaria in South America and 
Asia) infected Red Blood Cells. Importantly, we presented and described a 
package-structured code in R programming language used to rapidly process the 
P. vivax lipidomics data. This program acquires monoisotopic features from a 
Mass Spectrometry experiment to be processed in a subsequent Tandem MS 
experiment. It also identifies particular lipid species by working coupled to 
MSPepSearch and gives hints on lipid classification given a database of 
Precursor Ion and Neutral Loss Scans. 
This novel pipeline was used to identify lipids being over expressed in 
reticulocytes infected with P. vivax in comparison with non-infected 
reticulocytes and the results are discussed in terms of an extensive literature 
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Introduction: Part I, Lipidomics 
 
The lipidomics field 
The state-of-the-art of the research in science is characterised by the availability of 
technical approaches that allow a “to-down” interpretation of the biological systems. 
Together with the well-known fields of genomics, transcriptomics and metabolomics 
is the newer lipidomics discipline, which studies the large-scale identification of lipids 
and their interacting moieties (Wenk, 2005). The untargeted systems-level approach of 
lipidomics is an innovative and unbiased way to study the phospholipid composition of 
biological entities. The general idea of one of the current and most common methods 
for the description of such lipids is to use a Mass Spectrometer to identify the exact 
mass of a previously purified and ionized non-water-soluble metabolites followed by a 
second step of ionization after fragmentation that can lead to the identification of 
fragment ions that give structural information for a single lipid molecule. However, 
other experimental approaches can also be used like nuclear magnetic resonance 
(NMR) or Biochemistry assays, nonetheless, they allow only a low-throughput 
analysis. 
The rapid improvement in lipid extraction protocols and the better signal-to-noise ratio 
in new mass spectrometers, have made possible to produce lipidomics studies using 
samples of limited quantity; for example in the study of the membrane composition of 
Escherichia coli (Oursel et al., 2007) or of plant lipids (Welti & Wang, 2004). Other 
cases are the comparative lipidomics, in which two or more related biological samples 
are compared such as the work of Singh et al. (Singh & Prasad, 2011) where they 
compared the lipid profiles of a sensitive and a resistant strain of the fungus Candida 
albicans, the identification of common and unusual polar lipids in the Apicomplexa 
parasite Toxoplasma gondii (Welti et al., 2007) or in mammalian organisms exploring 
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the effect of toxic compounds in the lipid composition of the liver by using NMR 
(Fernando, Bhopale, Kondraganti, Kaphalia, & Shakeel Ansari, 2011). 
When a global search is performed using a single method in order to obtain a broad 
lipidomics coverage from a given sample, the study is called untargeted and comes with 
some advantages as well as some disadvantages. It can be used when the identity of the 
lipid target is unknown or several lipid classes are required to be analysed 
simultaneously with a quantitative output (Layre & Moody, 2013). 
 
Basics of Mass Spectrometry 
The only technique that can manage the analysis of thousands of different lipid 
molecules in a single run is Mass Spectrometry (MS). In principle, it does not require 
an initial separation of the sample but a direct infusion can be used (Li, Yang, Bai, & 
Liu, 2014). However, complex samples like tissues or body fluids can contain 
thousands of distinct lipid species (Layre & Moody, 2013). Coupling MS with a 
chromatographic separation can improve the identification by separating the inputs by 
lipid class or size. 
For some authors the introduction of lipidomics started with the development of the 
Electrospray Ionization (Han & Gross, 2003; Li et al., 2014) where the idea is to apply 
an electric field to a liquid (the lipid extraction) in order to induce a charge, then, and 
after desolvation, charged lipids are separated by its mass-to-charge (m/z) ratio which 
is the ultimate goal of the Mass Spectrometer (Hoffman & Stroobant, 2007). When 
coupled to a liquid chromatography column, an additional dimension of information is 
generated for each component of the sample which is the retention time, this value 
depends on chemical properties like the length of the fatty acids, the volatility and 
polarity of the molecule and even the location of double bonds in the fatty acids 
(Dobson, Christie Ww Fau - Nikolova-Damyanova, & Nikolova-Damyanova). 
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For lipid identification purposes, molecules with a single charge are desired, as their 
m/z ratio will correspond to its mass. However, the number of charges acquired by a 
molecule will depend on how many ionisable sites has this molecule, which is a 
property that can correlate with its size. For example, cardiolipin, a phospholipid 
characteristic of the mitochondria, usually acquires a double charge (Han, Yang, Yang, 
Cheng, & Gross, 2006). 
Mass spectrometers using a Quadrupole Time-of-Flight (QTOF) can positively or 
negatively ionize the sample giving rise to two sets of measurements, one 
corresponding to molecules that can get a positive charge, denoted by [𝑀 + 𝐻]+ like 
in the case of phosphatidic acid (PA), phosphatidylglycerol (PG), phosphatidylinositol 
(PI), phosphatidylserine (PS), inositolphosphoceramide (IPC) and diacylglycerol (DG), 
or a negative charge as in the case of sterols, phosphatidylcholine (PC), triacylglycerol 
(TG), ceramide (Cer) and also DG (Ejsing et al., 2009), to mention some. 
The mechanism used by a QTOF mass spectrometer (QTOF-MS) relies on accelerating 
the ions coming from a fragmentation of a ‘precursor ion’, they will have the same 
velocity as the precursor but different kinetic energies depending on their masses. 
Consequently, these ions will have different flight times (thus the name: time-of-flight). 
The resolution of such instruments will be proportional to the length of the flight path. 
Although the most sensitive devices on the market have several systems to reduce false 
negatives (ion suppression), and obtain high accuracy on complex samples, the 
obtained data is the result of adducts, fragments and isotopic peaks that must be further 
analysed and interpreted (Tautenhahn, et al. 2008). Herein, the term “feature” will refer 





Natural molecules are composed of isotopes, which are atoms of the same chemical 
element with different masses. Considering the most common elements present in 
lipids, the lightest isotope is always the most abundant (Berglund & Wieser, 2011). 
Table 1 shows the most common heavy isotopes that can be found in lipid species. 
Sulfur has the biggest isotope variation, however it is rather restricted to particular 
lipids like cholesterol sulfates (e.g. in brain, kidney, and other mammalian tissues) or 
taurolipids (e.g. in the bile acids, in Tetrahymena and rarely in plants), between others 
(Ishizuka, 1997). 
The isotopes 13C, 33S and 15N are the next most abundant and they all contribute to “+1” to the 
mass of the molecule that contains them. The isotopes 18O and 34S, if present, will lead to “+2” 
to the mass of the lipid. 
 
Table 1 
Isotope Mass [Da] % Abundance 
31P 30.973763 100 
1H 1.007825 99.985 
16O 15.994915 99.76 
14N 14.003074 99.63 
12C 12.000000 98.90 
32S 31.972072 95.02 
34S 33.967868 4.21 
13C 13.003355 1.10 
33S 32.971459 0.75 
15N 15.000109 0.37 
18O 17.999159 0.20 
17O 16.999131 0.038 
2H 2.014102 0.015 
 
Table 1. Natural abundance of isotopes commonly present in lipid species. Data ordered by abundance 
and obtained from the latest report from IUPAC (Berglund & Wieser, 2011). 
 
To illustrate the effect of the isotopes to the distribution of the m/z values of a simple 
molecule, we will consider the alkane C20H42. The most abundant molecule, based on 
Table 1 will be the molecule composed of twenty 12C atoms and forty-two 1H atoms 
with a probability of 0.98920 x 0.9998542 which is 0.7998757, then we can calculate the 
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mass of this molecule as 12.000x20+1.007825x42 which is 282.3286. Similarly, we 
can obtain the mass and probability for the second most likely alkane of 20 carbons, 
assuming the distribution values from Table 1. Table 2 summarizes just the first three 
theoretically most common molecules. 
 
Table 2 
Molecule Exact mass Abundance Normalized Abundance 
12C201H42 282.3286 0.7999 0.8033 
12C1913C11H42 283.332 0.1772 0.1779 
12C1813C21H42 284.3354 0.0187 0.0188 
Sum: 0.9958 1 
 
Table 2. Example of the abundance of some isotopes of C20H42. The abundance was calculated using the 
values from (Berglund & Wieser, 2011). The normalized abundance is presented to explain the 
proportion of the peaks in a mass-to-abundance plot. 
 
The mass of a molecule considering only the most abundant atoms is called 
monoisotopic mass and the monoisotopic mass spectrum refers to the spectrum that 
contains the molecules made up of the first most common isotopes. For small molecules 
like C20H42, the most likely, or abundant, mass will be the monoisotopic mass (see Table 
1 and Figure 1). However, it is easy to note that for bigger molecules the probability to 
find a heavier isotope increases. Given that Mass Spectrometers are able to distinguish 
isotopes, the monoisotopic mass will be used hereafter in this thesis instead of any other 




Figure 1. Relative abundance of the three most common isotopic masses of the alkane C20H42 based on 
the abundances reported by (Berglund & Wieser, 2011). An approximate difference of ‘+1’ in the mass 
value is observed in the molecule containing one 13C atom with a significant relative abundance of 
~17.8%, which corresponds to ~17.7% in natural observations (see Table 1). The third isotopic peak and 
all other not-depicted heavier isotopes are very rare. 
 
Adducts 
Neutral molecules can get ionized not only with a proton but with another ion, when 
this occurs the product is called adduct. Examples of ‘ionizing’ ions are sodium, 
potassium, ammonium, chloride and acetate. The production of adducts with depend 
on the head group of the lipid, how carefully it was desalted or the solvent used for the 
lipid extraction (Hoffman & Stroobant, 2007). 
 
Tandem Mass Spectrometry 
Current Mass Spectrometer instruments allow the discrimination of masses with a mass 
accuracy under 1 ppm (as with the 6550 iFunnel QTOF-MS from Agilent) 
corresponding to +/- 0.0016 m/z for heavy lipids. However different molecules with 
the same atomic composition can have different chemical properties and structures. For 
example, the compounds Palmitoyl-EA, 3-ketosphinganine and Sphingosine have all 
the same composition: C18H37NO2 but different structures (Fig 2.) and will produce a 
peak at the same m/z value. Tandem Mass Spectrometry (Tandem MS or MS/MS) is a 
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procedure where the fragmentation of a previously isolated monoisotopic ion (the 
precursor) is used to analyse in a mass spectrometer again the mass of its components. 
A precursor ion carrying only one charge can be fragmented by collision with an inert 
gas into a lighter ion and a neutral fragment. By using Tandem MS, molecules like 
Palmitoyl-EA and Sphingosine can be distinguished as fragmentation patterns will be 
different, even differences in stereochemistry can lead to different spectra (Hoffman & 
Stroobant, 2007). 
 
Figure 2. Structure of three molecules with the same atomic composition but different structure. From 
top to bottom: Palmitoyl-EA (LMFA08040013), Sphingosine (LMSP01010001) and 3-ketosphinganine 
(LMSP01020002). In parenthesis are the identifiers in Lipid MAPS database. 
 
In further detail, the measurements obtained in an MS/MS experiment can be divided 
in, but not restricted to, ‘product ion scan’ or ‘neutral loss scan’. The difference relies 
on which fragment is being determined, if the charged molecule or the complementary 
molecule (without charge). 
To exemplify some of the rules governing the fragmentation patterns in a Tandem MS 
experiment, the synthetic ceramide 1,3-di-O-trimethylsilyl-N-stearoyl sphingosine will 
be used (Samuelsson & Samuelsson, 1960). For the sake of simplicity, rounded 
numbers (to integers) will be used, which is the way MS research was performed before 






and pure molecule but positively charged, is submitted to electron impact, the following 
ions will be observed: one ion at m/z=694 (15 units at the left of the precursor ion, also 
represented as [M-15]+ indicating the loss of 15 m/z units leading to a positive ion) 
corresponds to the precursor after losing a methyl group (CH3, with mass 15 Da). Other 
molecules can be separated like trimethylsilanol (90 Da) or the terminal methylene (103 
Da) giving rise to ions with m/z values of 619 and 606, respectively. The fatty acid with 
18 Carbons labelled with the letter ‘b’ in Figure 3 can form a fragment with the 
molecular formula C18H36N1O1 (282 Da), however, and in order to generate a molecule 
with a positive charge (also called ‘product ion’) only molecules that have lost a neutral 
fragment will be detected (called ‘neutral loss’) giving rise to the retention of an 
additional Hydrogen [M-(282+1)]+ with a peak at m/z=426. Additional combinations 
generated by the simultaneous loss of the 18-Carbons fatty acid and the trimethylsilanol 
([M-283-90]+) will create the peak at m/z=336. Another option is the cleavage between 
C-2 and C-3, creating the fragments labelled as ‘a’ (M-d; m/z=311) and ‘d’ (M-a; 
m/z=398), where the last one has the highest abundance making it the reference for the 
rest of the peaks. Finally, more complex fragmentations can occurs as in the case of the 
peak at m/z=471, where a cleavage between C-2 and C-3 was followed by a transfer of 
the trimethylsilyl (73 Da) group to the remaining molecule ([M-(a-73)]+). 







Figure 3. The fragmentation spectra of the synthetic ceramide 1,3-di-O-trimethylsilyl-N-stearoyl 
sphingosine (depicted at the m/z=709 with a gray dashed peak) based and simplified from the data 
published by (Samuelsson & Samuelsson, 1960). TMS, trimethylsilyl. 
 
Processing of Mass Spectrometry Data 
Mass Spectrometry experiments preceded by Liquid Chromatography (LC) can 
produce massive amounts of data (more than three thousand signals per experiment) 
that require a special preprocessing before well-behaved and reproducible peaks can be 
identified. Information on peak intensity and the mass-to-charge ratio can be used 
together with the retention time that is dependent on the used chromatographic column 
for data filtering and correction. 
In order to compare more than one MS experiment, discreet and aligned peaks defined 
by m/z and intensity values are needed. Such alignment can be performed with XCMS 
(Smith, Want, O'Maille, Abagyan, & Siuzdak, 2006), a software written in R 
programming language for metabolomic analysis. It has become broadly used and a 
proof of its success is the publication of several improvements to either the feature 
detection algorithm (Tautenhahn, Bottcher, & Neumann, 2008) or to the online version 
(Gowda et al., 2014) which is user-friendly although less flexible as will be deeply 




Bioinformatics tools for structure identification of lipids 
The process previously described for the identification of the structure based on 
Tandem MS data can be automatized to identify possible ions with a known m/z value 
or combinations of them. This will essentially depend on how big, specific and accurate 
the database of spectra is. As further discussed in the next section, a big progress is 
needed in different aspects of the lipidomics research and one of them is the 
development of databases fulfilling the mentioned characteristics. The best effort done 
so far, in quantitative terms, is LipidBlast (Kind et al., 2013). Published in 2013, this 
database contains computer-generated tandem mass spectra from 119,200 lipid 
compounds which surpasses almost ten times the total number of compounds from 
other libraries like Metlin, MassBank and NIST. It includes 26 lipid classes, including 
phospholipids, modelled under different observed adduct ions in, both, positive and 
negative ionization modes. The construction of the library is based on Lipid MAPS and 
associated tools (Fahy, Sud, Cotter, Cotter, & Subramaniam, 2007) but generously 
complemented with lipids found in chloroplasts, including mono and 
digalactosyldiacylglycerols as well as sulfoquinovosyldiacylglycerols (Benning, 
2008). Given that ion abundance patterns can be instrument-specific, LipidBlast 
modelled spectra for different mass spectrometers, including QTOF-MSs. 
The next step is the identification of the spectra of an unknown compound within a 
given library in a reasonable time and the assignment of a score that will allow the 
discrimination of a true positive. NIST MS Search Program (Stein & Scott, 1994), 
developed by the National Institute of Standards and Technology, performs such search 
based on a two-step algorithm. Briefly, the peaks of the query and the library are scaled 
by their abundance and m/z values. Then, and starting with the highest scaled peak in 
the query, one by one the peaks of the query are compared with a subset containing the 
most intense peaks in the scaled library. The way NIST MS Search solved the problem 
of scoring the hit results is by taking advantage of a multidimensional hyperspace, 
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where each mass spectrum will represent a single point described by a vector with the 
intensity values for each m/z variable. Thus, when a query and a target spectra are 
identical, both point representations will coincide, while two similar spectra will have 
point representations close to each other. The similarity can be measured with the dot-
product of the vectors describing both points. An improved scoring system also 
considers the ratios of adjacent peaks. The mentioned algorithm is implemented in a 
Graphical User Interface for easy manual inspection (Download from: 
http://chemdata.nist.gov/) or in a high-throughput mode (Download from: 
http://peptide.nist.gov/software/ms_pep_search_gui/MSPepSearch.html). 
 
Data analysis: The normalization in untargeted Mass Spectrometry 
analyses 
As mentioned before, lipidomics is still an emerging field and not as developed as other 
system-level approaches. Thus, some methodologies for the processing of the data 
obtained on MS or MS/MS experiments are still under discussion. For example, there 
is some controversy regarding the use of normalization methods; below are discussed 
some opposing approaches to data normalization. 
It has been proposed the median fold change normalization, which centers each 
distribution in the median of the fold changes, to reduce dilution-induced variation in 
metabolic profiles using ultra-performance liquid chromatography/MS (UPLC/MS) 
(Veselkov et al., 2011). The same procedure was used in a very recent study applying 
UPLC/MS to assess radiation-induced metabolic changes in human fibroblasts (Kwon 
et al., 2014). 
 Another group proposed quantile normalization to compare metabolomic data from 
different LC-MS studies (J. Lee et al., 2012), this method is the standard for the analysis 
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of microarrays for gene expression, where the distribution of the intensity values from 
the different samples are adjusted to be similar in statistical properties. 
There are different, and sometimes inconsistent, ways to evaluate a normalization 
procedure. Some authors use a multiparametric method like Principal Component 
Analysis (PCA) to verify that replicates cluster together. Other options are to make 
boxplots of the intensity values per sample, quantile-quantile plots or by observing the 
standard deviation of signal intensity as a function of the Quality Control (QC) 
intensities ordered by ranks (Veselkov et al., 2011) (J. Lee et al., 2012). 
It is important to note that in the transition from research to the clinical practice, 
microarray and high-throughput sequencing technologies needed an optimized 
framework for quality control. The project regulating this is called MAQC (for 
MicroArray Quality Control) for the case or microarrays and SEQC for next-generation 
sequencing (Shi et al., 2006) (DeLuca et al., 2012). Nothing similar has been published 
yet for lipidomics studies showing the importance in discussing the current tools and 
pipelines to process this kind of data. 
 
The R programming language 
R is a programming language for statistical computing that has been widely used to 
develop tools for the analysis of high-throughput biological data. It works through the 
addition of ‘packages’ which are sets of functions or subroutines that are developed by 
the scientific community. With the aim to centralize, quality assess users-developed R 
packages, a repository called Bioconductor was created in 2001, since then, tools 
required for the new technologies have been evaluated and distributed by this repository 
(Gentleman et al., 2004). 
The package structure allows a high degree of flexibility during the processing of data, 
as several independent functions, either previously published or in-house developed, 
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can be concatenated. R is also an easy language for statistical analyses and the creation 
of graphics. Furthermore, the design of a purely automated pipeline gives the warranty 
of the reproducibility of the results. 
The previously mentioned XCMS software for processing of MS is an example of a 
package distributed by Bioconductor, illustrating how different systems approaches 






Introduction: Part II, Malaria 
 
Malaria overview 
Malaria in humans is caused by five different parasites, Plasmodium falciparum, P. 
vivax, P. ovale, P. malariae and P. knowlesi. The scientific knowledge on the P. vivax 
biology if far less than what it is known for P. falciparum, however, the global 
population at risk is comparable (2.5 billion people live at risk of infection of P. vivax 
(Gething et al., 2012)) and it has been recently called as serious and threatening as P. 
falciparum infection (Baird, 2013; Quispe et al., 2014). 
 
Life cycle of Plasmodium vivax 
The malaria infection starts with the bite of an infected female mosquito from a 
susceptible species from the genus Anopheles that will release few parasites at the 
sporozoite stage. In the dermal tissue they are motile and move to small blood vessels 
that will allow them to reach the liver where they are engulfed by Küpffer cells to 
consequently penetrate a hepatocyte, the place where the parasite will differentiate to 
small trophozoite and after five days to a multinucleated schizont. By day six or seven 
the mature schizont will undergo a rupture to generate thousands of single nucleated 
merozoites that will find a way to get to the blood circulation where they invade 
reticulocytes (that are the young erythrocytes characterized by the expression of the 
CD71+ marker (Malleret et al., 2014)) which comprise only 1-2% of circulating 
erythrocytes (Kitchen, 1938). Once in the infected red blood cell (iRBC, or the host 
cell), the merozoite starts the differentiation to an erythrocytic trophozoite, and 
remodels the host cell by creating a parasitophorous vacuole, cleft structures and 
caveolae-vesicle complexes (Aikawa, Miller, & Rabbege, 1975; Malleret et al., 2014). 
During the next 48 hours it feeds upon haemoglobin and divides around four times to 
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generate 12-16 new merozoites, the intermediate stage before the cellular division and 
after the nuclear division is also called schizont, only some of those schizonts will 
develop into gametocytes which are sexual stages that can survive in the invertebrate 
host closing the life-cycle. 
Unlike P. falciparum, the P. vivax infected erythrocyte becomes quite deformable 
(Handayani et al., 2009; Suwanarusk et al., 2004) and promotes more rosetting events 
which is the adherence of uninfected erythrocytes to an infected one. The rosetting was 
historically thought as a mechanism to attract future hosts for the releasing merozoites 
reducing, this way, their time in the peripheral blood. However, it has been recently 
shown that in the case of the P. vivax infection, these rosetting complexes are mostly 
made up mature erythrocytes (also named normocytes)(E. Lee et al., 2014). 
An additional characteristic of this malaria infection is the development of an additional 
life stage in the liver named hypnozoite, a dormant form that enables recurrent blood 
stages infections after months or even years from the first infection (Reviewed in 
(Mueller et al., 2009) and (Galinski, Meyer, & Barnwell, 2013). Further details of the 
biology of this parasite are beyond the scope of this thesis. 
 
Malaria vaccination and treatment 
Currently there are no licensed vaccines against malaria, despite more than 20 vaccine 
candidates in clinical trials; only one is in Phase 3 (RTS,S/AS01) which targets P. 
falciparum (Agnandji et al., 2012), leaving vivax malaria without any vaccine for the 
near future. 
For the treatment of P. vivax infection, the recommended drug by the World Health 
Organization is the chloroquine in areas where it is still effective. In the countries where 
resistance has been confirmed the alternative treatment is the artemisinin-based 
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combination therapy, to eliminate the liver stage primaquine is used (Report, 
2013)(World Malaria Report, 2013). 
An additional problem associated with malaria eradication programs is the absence of, 
or a correct, molecular typing to measure incidence of the different Plasmodium species 
between asymptomatic people (Fru-Cho et al., 2014). This is a similar situation with 
the incorrect diagnosis of mixed infections as different species have different levels of 
parasitemia, explained by the different used cell hosts (Kitchen, 1938) (Mueller et al., 
2009). Furthermore, interventions exclusively targeting P. falciparum in mixed 
infections are insufficient to eliminate the disease (Genton et al., 2008) and new species 
can be adapting to human cells as it was the case with the recently described naturally 
acquired human infection with P. cynomolgi (Ta et al., 2014). 
 
Overview of the phospholipid metabolism in Plasmodium spp. 
After the merozoite attaches, reorients and forms a junction, the parasite releases the 
content of rhoptry and microneme organelles which include proteins and lipids that 
participate in the formation of a parasitophorous vacuole membrane (PVM). The 
surface area of this structure corresponds to approximately 3% of the total area of the 
erythrocyte right after the endocytosis (Holz, 1977). 
This initial contribution of biomass corresponds to a minimal proportion of the material 
needed to construct, maintain and increase in size (up to five times the content of 
phospholipids) the components of the PVM (Mitamura & Palacpac, 2003). 
Given the importance of the phospholipid metabolism in the survival of the parasite, it 
represents a target for drug discovery research as well as an open field for the 
development of biomarkers Plasmodium species-specific. 
The enzymes participating in the biosynthesis of fatty acids (FAs) can be divided in 
two categories, large multifunctional proteins (type I fatty acid synthases) are present 
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in mammals, fungi and some mycobacteria while the type II fatty acid synthases, where 
separate enzymes catalyse step by step the fatty acid production, are present in plants 
and most bacteria. 
Species from the phylum Apicomplexa are unicellular Eukaryotes that parasitize 
vertebrates or invertebrates, some examples are the member of the genera Babesia, 
Crystosporidium, Eimeria, Theileria, Toxoplasma and Plasmodium. The evolutionary 
history of the Apicomplexa has its origins in two subsequent endosymbiosis events, a 
cyanobacterium was engulfed by a heterotrophic eukaryote that was subsequently taken 
up by an auxotrophic protist. The initial photosynthetic function of the organelle that 
initially was a cyanobacteria was lost as this organisms acquired a parasitic life-style 
keeping them away from sunlight (Reviewed in (van Dooren & Striepen, 2013)). The 
now organelle received the name of Apicoplast. With the uptake of additional genetic 
material encoded by that ancient cyanobaterium, some metabolic pathways were 
integrated to the host organisms in processes like energy transport and storage. 
However, some of the encoding genes were translocated to the nucleus where they are 
transcribed and then with the help of signal peptides they are targeted back to the 
apicoplast. Examples of these genes are acpP, fabH and fabZ which are involved in the 
type II fatty acid biosynthesis (Waller et al., 1998). 
Mature erythrocytes are depleted of machinery used to synthesize new lipids and cannot 
endocytose, indicating that any changes observed in the membrane are products of 
degradation or are the result of metabolism of the infecting parasite (Lingelbach & 
Joiner, 1998). It is known that Plasmodium performs the de novo synthesis of 
phospholipids like phosphatidylcholine (PtdCho) from choline or 
phosphatidylethanolamine (PtdEtn) from Serine. Additionally, it has been shown that 
in P. falciparum the de novo synthesis of fatty acids takes place during the erythrocytic 




Aims of project 
In contrast to P. falciparum, nothing is known about the lipid metabolism in P. vivax 
infected red cells. Our limited understanding of the lipidomic profile and general 
biology of P. vivax largely stems from the inability to continuously culture this species 
(continuous culture of P. falciparum was achieved in the 1970s (Siddiqui, Schnell, & 
Geiman, 1970)). Another hurdle worth mentioning has been the lack of knowledge on 
the metabolic differences between reticulocytes (of varying stages) and normocytes, in 
particular in terms of phospholipid composition (Malleret et al., 2013). This is 
important as P. vivax only invades early stage reticulocytes and never normocytes.  
Given this background, this study seeks, first, to develop a bioinformatics pipeline, 
organized as an R-package, for the data analysis of MS and MS/MS experiments that 
can be applied to different sample comparisons. Secondly, to characterise the lipidomic 
profile of immature reticulocytes isolated from human cord blood cells (to provide us 
with the background lipid profile) to that of P. vivax-infected cord blood reticulocytes. 






Materials and Methods 
 
In this section, the first part summarizes the samples and previously done experiments 
that generated the data used for the analysis. The second part describes the procedures 
and functions written in R code to identify the candidates for the MS/MS experiment 
as well as the downstream processing of the information obtained by the MS and 
MS/MS experiments. 
 
Description of the data. 
Four P. vivax, and one P. falciparum clinical isolates were previously obtained from 
Shoklo Malaria Research Unit in northwestern Thailand by the group of Dr. Francois 
Nosten. The isolates were maintained in human cord blood cells following recently 
published protocols (Malleret et al., 2014) at the P. vivax laboratory of the National 
University of Singapore and processed for lipid extraction in two batches at the 
Singapore Lipidomics Incubator, at the National University of Singapore using 
published protocols (Narayanaswamy et al., 2014). For the Experiment 1, eight 
samples, described in Table 3, where identically processed. 
 
Table 3 








Pf1 RBC P. falciparum Negative ~90 mill. 2 
Pf2 RBC P. falciparum Positive ~90 mill. 2 
PvFE1 Cord Blood Reticulocytes P. vivax Negative ~10 mill. 2 
PvFE2 Cord Blood Reticulocytes P. vivax Positive ~2 mill. 2 
CBNorm1 Cord Blood Normocytes NA NA ~1 mill. 2 
ReticFE1 Cord Blood Reticulocytes NA NA ~1 mill. 2 
uRBC1 RBC NA NA ~90 mill. 2 




Table 3. Description of the samples used for the first experiment. # tech. replicates, number of technical 
replicates; RBC, red blood cells; MACS, magnetic-activated cell sorting; NA, not applicable; mill, 
millions. 
 
Pf1 and Pf2 are the negative and positive fractions from a cell sorter that separates 
DNA-containing cells (positive fraction) or not (negative fraction), respectively. PvFE1 
and PvFE2 were separated using the same method. CBNorm1, ReticFE1 and uRBC1 
are cell cultures that never had contact with parasites. Cord Blood Reticulocytes were 
sorted from normocytes by using the CD71 marker. Blank1 is a cell-free sample that 
followed the same lipid extraction protocol and will be used as a control for 
contamination during the lipid extraction process and the mass spectrometer 
performance. Cell count was used for normalization for the phospholipid extraction 
that was used as input in an Agilent 6550 iFunnel LC-ESI-QTOF-MS. 
A second experiment (Experiment 2) enlarged the sample size exclusively for P. vivax 
infected cells. Table 4 describes the samples. 
 
Table 4 

























NA 0 0.120 3 
 
Table 4. Description of the samples used for the second experiment. Parasitemia indicates the percentage 
or reticulocytes being infected. NA, not applicable. 
 
The reticulocytes sample was exactly the same culture that was used to infect with three 




Lipid extraction and Mass Spectrometry experiments 
The protocol followed for the lipid extractions in both experiments were based on a 
non-targeted profiling of lipids, thus no internal standards were used. The first 
experiment focused on phospholipid recovery while the second one targeted 
phospholipids as well as sterols. All the samples were processed twice in the Mass 
Spectrometer, and in the case of the non-infected reticulocytes for the second 
experiment three times, to give technical replicates. 
 
Data analysis 
mzdata files from Experiments 1 and 2 where processed in the same way except for a 
normalization step in the case of the samples where the cells were not counted 
(Experiment 2). There, normalization of the intensity values was performed based on 
protein estimation (See Discussion section for details about the normalization 
procedure chosen). 
 
Feature detection and alignment of features 
The standalone version of the software XCMS v1.38 (Smith et al., 2006) was used for 
feature detection with the centWave algorithm appropriate for high resolution LC/MS 
data sets (Tautenhahn et al., 2008), considering 30 parts per million as the maximal 
tolerated m/z deviation in consecutive scans, a range of 15 to 30 for the tolerated peak 
width, the default, obiwarp, method for retention time correction, a value of 0.015 for 
the width of the m/z windows used to group peaks and to create the peak density 




Design of code to select candidates for MS/MS 
Three types of data were present in both experiments, a negative control or blank, an 
infected sample and a non-infected sample. The general idea was to identify highly 
expressed features in a negative control, subtract them from the total set of features and 
then to identify the features being present with a significant higher intensity in the 
infected sample compared to the non-infected cells. 
In detail, after the feature detection and alignment done by XCMS v1.38, the error rate 
is calculated per set of technical replicates. Assuming that a true and characteristic 
metabolite should appear in all the samples but considering some errors in the detection 
of the mass spectrometer and in the feature detection method, a threshold of 66% was 
used to eliminate those features lacking reproducibility based on technical replicates, 
(this filtering step was done by using filterIntensity.R, see Appendix B for full code). 
The next step was the subtraction of false positives. To perform this, the fold change 
and p-value (two sided Student’s t-test) are calculated using not normalized intensity 
values. Those features appearing 1.5 times or more in the blanks than in the rest of the 
samples as well as having a p-value equal or lower than 0.05 are considered as false 
positives and are discarded (see function removeFalsePositives.R in Appendix B). 
For the case of the Experiment 2, as the cell count was not known, six different 
normalization strategies were tested in order to be able to compare infected and non-
infected samples. ‘Quantile normalization’ normalizes the distribution of intensities per 
sample making each sample to have the same quantiles (Bolstad, Irizarry, Astrand, & 
Speed, 2003), this method is taken from the R package limma v3.18.13. ‘Total Sum’ 
assumes that the same lipid content is present on each sample so the total sum of 
intensities per sample should be the same. ‘Median Fold by Sample’ centers each 
distribution in the median of the fold changes, where the median values are obtained 
by sample, for technical reasons all zero values reported by the mass spectrometer are 
changed to 1. ‘Median Fold by Feature’ also centers the distribution in the median of 
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the fold change but obtaining the median values per feature, this follows the idea and 
code reported in (Veselkov et al., 2011), the authors suggested to use a replacement of 
0.0001 in the zero values. ‘Median Fold (limma)’ this method also centers the 
distribution in the median of the fold changes so that each sample has the same median 
value, it follows the method called normalizeMedianValues from the limma package 
(v3.18.13) (Smyth, 2005). ‘Protein Estimation’ considered the values of protein 
estimation shown in Table 2 to make proportional the ratios in total sum of intensity 
values with the protein estimation per sample. These strategies are implemented in the 
function featureNormalization.R which can receive the columns of the blanks not to 
consider this data (see Appendix B for full code). 
The same way the fold change and p-values are calculated for the blanks, these values 
are obtained for the infected cells versus the control samples (the filter is implemented 
in the function fcpvalue.R, see Appendix B for full code). 
Two consecutive filters delimit the features in an m/z and retention time range that fits 
the lipid extraction protocol. For the Experiment 1, as mentioned earlier, it is expected 
to recover only phospholipids, then a lower m/z value of 400 was set, while for the 
Experiment 2 the lower limit was set to 300. In both cases no upper limit for m/z was 
fixed. The range for retention time was set from 3 to 14 minutes. These parameters can 
be easily customized in the functions mzmedFilter.R and rtFilter.R as shown in 
Appendix B. 
The next filter retains only those features being highly present in samples or in controls, 
named ‘UP’ or ‘DOWN’ features, respectively. The fold change cut off was set as 1.5 
and the p-value as 0.05. The function implementing this is UPorDOWNregulated.R 




In high-resolution instruments like QTOF-MS, the ‘exact mass’ of a molecule can be 
calculated and peaks from different isotopes can be observed. With the attempt to 
obtain only one peak per molecule, the most abundant isotope will be sought. In the 
case of lipids, and as mentioned in the introduction section, the highest peak will 
coincide with the molecular mass resulting from the sum of the most abundant isotopes 
of each of its atomic constituents and this will be referred as the monoisotopic mass. 
To further simplify the analysis, only single-charged molecules will be considered. 
Then, the monoisotopic mass will correspond to the monoisotopic m/z value. 
Theoretically, at least the first isotope should be also present in the data in a smaller 
proportion as the monoisotopic peak. All these observations are taken into account in 
the isotopeFilter.R function which calls the Isotope.R function that retrieves the closest 
possible isotope to a given m/z and retention time values, considering a threshold, or 
error window, for m/z (0.015) and retention time (3 seconds). This function can be 
adapted to identify isotopes with either higher or lower mass, in other words, to find 
the [M+1] isotope assuming the given mass corresponds to a monoisotope, or the [M] 
when the [M+1] is given. It is also possible to specify if the feature that is being 
searched must have a higher or a smaller intensity compared to the query feature. 
Finally, an option to search for double charged features can be set, that is, features that 
are separated by a 0.5 value in the m/z dimension, considering the mentioned threshold. 
Then, isotopeFilter.R creates a table with the features that correspond to monoisotopes. 
To do so, it discards features that appeared at the [M+1] or [M+0.5] position from 
another feature with higher intensity. Same for those without at least the [M+1] isotope. 
Actually, the features identified as coming from a double-charged metabolite are 




Figure 4. Three examples of features eliminated by the ‘Isotope filter’. The bar in red is the one being 
eliminated while the black can be retained. From left to right: a possible monoisotope overlapping the 
[M+1] isotope as predicted by the intensity values; a possible [M+1] isotope, and a probable 
monoisotope lacking [M+1] or [M+2] isotopes. 
 
The script used to call all the different functions and to produce the different graphs 
and tables containing intermediate outputs as well as the four final lists of candidates 
(two for each mode, one for each UP and one for each DOWN expressed features) is 
named ObtainingCandidates.R and the full code is present in Appendix B. 
The only two dependencies of the described pipeline are the Bioconductor packages 
‘xcms’ (Smith et al., 2006) and ‘limma’ (Smyth, 2005). 
To sum up the designed pipeline for the identification of candidates for the MS/MS 
analysis Figure 5 shows the general flux diagram. 
 
 
Figure 5. Flux diagram for the identification of differentially expressed monoisotopic features to proceed 
to MS/MS. Experiment 1: red arrows; Experiment 2: blue arrows. Yellow symbols indicate steps where 




Analysis of Tandem MS data: Lipid identification 
mgf is the format of the files generated by a QTOF MS/MS instrument, one for each 
ionization mode and one for each input sample. This files contain sets of ion peaks 
defined by m/z and intensity values, one for each precursor (which in this case will 
correspond to one for each of the selected ‘candidates’) and can be present different 
times in the file with different retention times. When using the same column for the 
Liquid Chromatography as the one used for the MS experiment, it is possible to narrow 
down the number of spectra in order to select only those precursor ions analysed at the 
correct retention time, as this value will be constant with a margin to tolerate some 
technical variances. Thus, the first processing of the MS/MS data consists in selecting 
the spectra that corresponds to the m/z and retention time values of the candidates from 
the MS analysis in a window of 0.015 units for m/z and 30 seconds for the elution time. 
The function extractingSpectra.R will generate new mgf files with the spectra with the 
expected retention time (see full code in Appendix B).  
The software NIST MSPepSearch 
(http://peptide.nist.gov/software/ms_pep_search_gui/MSPepSearch.html) is used for a 
high-throughput search of Tandem MS data against a given database of mass spectra. 
In this case, the LipidBlast database as well as custom libraries for Ceramides, 
Cholesteryl esters, Lysophosphatidylcholines, Phosphatidylcholines, Sphingomyelines 
and Lyso phosphatidic acids (Kind et al., 2013) were used, setting an m/z range of 200-
1500, precursor ion tolerance of 0.015 and fragment peak m/z tolerance of 0.2, 
minimum match factor to output to 50. 
The tsv files generated by MSPepSearch are then processed in R with the following 
functions: getRTmins.R parses the files to include a column with the retention time in 
seconds (See full code in Appendix B). The different tables using the same sample but 
different databases are joined with the function concatenate.tsvs.R (see full code in 
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Appendix B). Then, as the same precursor can have more than one spectra (because of 
measurements at different retention times), the hits are merged into a table with one 
line per precursor and the values of ‘Lipid Class’, Adduct, Total number of carbons in 
the fatty acyls, total number of double bonds in the fatty acyls, Lipid Subclass, and 
number of carbons in the first, second and third fatty acyl (if exists). As different values 
can be assigned to different spectra from the same precursor, this information is 
considered only when the reverse dot product value is equal or higher than 600, which 
has been the best performing algorithm for library search identification (Stein & Scott, 
1994) (Kind et al., 2013). When there is more than one hit with a reverse dot product 
value higher than the threshold the information that is common between the high scored 
hits is kept. This procedure is implemented in the LipidClassAssignment.R function (for 
further details on this filter, such as the order in which the description of the lipid is 
assigned, see the full code and its corresponding comments in the Appendix B). 
An optional step to identify ‘well supported’ lipids is to integrate information from both 
ionization modes, as some lipid species can acquire a positive or a negative charge like 
DG, PA, PG, PI, PS, PE, Cer, Inositolphosphoceramide and Mannosyl-
inositolphosphoceramide (Ejsing et al., 2009). The function clusteringSpectra.R finds 
spectra from precursors with m/z values closer that a given threshold and determines if 
these spectra were assigned to the same lipid species (See Appendix B for further 
details and some comments about the clustering that uses the Adduct information).  
Additional functions were written to facilitate the analysis and handling of mgf files. 
For example, in the tsv files generated by MSPepSearch there is a column named 
‘Peptide’ with the name of the lipid species in a long word that contains the lipid class, 
the total number or Carbon atoms and double bonds, the adduct and ionization mode, 
the sub class and distribution of the carbons and double bond in the acyl chains (e. gr. 
‘PC 40:6; [M-Ac-H]-; GPCho(20:1(11E)/20:5(5Z,8Z,11Z,14Z,17Z))’). In order to 
separate this information the function splitPeptide.R receives the string and returns a 
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vector with the six mentioned arguments. This function is used in 
LipidClassAssignment.R to obtain these six values that will be compared between the 
different hits for the same precursor, the length of this vector can change to seven when 
the hit is a TG as it contains an additional fatty acyl. 
Another function is getMGF.R which is a useful code to generate an mgf file with the 
spectra belonging to a given m/z and retention time values. Given that some handling 
of the data, like changing the class of the values in R or saving the tables in Excel can 
modify the length of the decimal digits by rounding them, a small variant of the function 
getMGF.R (getMGF.feelinglucky.R) can help in finding values for m/z and retention 
time that can be originated by rounding. These three new functions are in the Appendix 
B. 
Finally, the filtered hits can be used to generate an mgf file for each of them with the 
function generateMGFs.R which receives the table with the filtered hits, the name of 
the sample and the mgf files produced by the Tandem MS experiment (See Appendix 
B for full code). 
 
Analysis of Tandem MS data: Ion Lookup 
For the alternative process of identifying lipid species by its similarity to a given 
database, a search can be done against a list of m/z values corresponding to well 
documented product ions that can give a hint on the identity of a lipid compound 
(Busik, Reid, & Lydic, 2009). In a similar fashion, data collected from Neutral Loss 
Scan can be used, but in this case the reported Neutral Loss is subtracted from the 
precursor ion and sought in the spectra of the MS/MS data. The list of values used for 
the scanning are summarized in Table 5, which was initially reported by (Busik et al., 
2009) where they only presented nominal masses, here the list was improved by 
collecting the exact mass from the original reference, from databases or calculated. An 
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extended list is presented in the Table S1 in the Appendix A, with additional m/z values 





Mode Precursor Ion MS/MS 
Scan 
Type 
Molecule Exact Mass Reference 
SM, 
GPCho Neg [M+Cl]- NLS CH3Cl 50.488 Busik2009 
SM, 
GPCho Neg [M+CH3OCO2]- NLS CH3OCO2H+(CH3)3N 135.1617 Busik2009 
SM, 
GPCho Neg [M+CH3OCO2]- NLS CH3OCO2+(CH3)3NCHCH2 161.1989 Busik2009 
SM, 
GPCho Pos [M+H]+ PIS Phosphocholine 184.150662 Han2005 
SM, 
GPCho Pos [M+Na]+ PIS Sodium cyclophosphane 147.022 Han1995 
GPCho Pos [M+Na]+ NLS Sodium cholinephosphate 205.1404313 Han2005 
SM, 
GPCho Pos [M+Na]+ NLS Neutral phosphocholine 183.150662 Brugger1997 
GPEtn Pos 
[M+H]+, 
M+Na]+ NLS Phosphoethanolamine 141.063 Brugger1997 
GPEtn Neg [M-H]- PIS 
Glycerol 
phosphoethanolamine 
derivative 196.0275 Han2005 
GPIns Neg [M-H]- PIS 
Dehydrated 
phosphoinositol 241.104602 Han2005 
GPIns Pos [M+NH4]+ NLS Phosphoinositol+NH3 277.166282 Busik2009 
GPSer Pos 
[M+H]+, 
[M+Na]+ NLS Phosphoserine 185.072 Busik2009 
GPSer Pos [M+Na]+ PIS Sodium phosphoserine 208.0617693 Busik2009 
GPSer Neg [M-H]- NLS Serine-H2O 87.0777 Han2005 
CE Pos [M+NH4]+ PIS Cholestane cation 369.3 Han2005 
MG, DG Pos [M+NH4]+ NLS H2O+NH3 35.0458 Busik2009 
GPGro Pos [M+NH4]+ NLS Phosphoglycerol+NH3 189.104222 Busik2009 
GPA Pos [M+NH4]+ NLS NH3+H3PO4 115.025702 Busik2009 
GPGro, 
GPA Neg [M-H]- PIS 
Cyclic glycerophosphate 
derivative 153.058442 Han2005 
GPIns Neg [M-H]- NLS Inositol unit -H2O 162.14058 Brugger1997 
GPIns Neg [M-H]- PIS [H2PO4]- 96.9872 Brugger1997 
SM 
Neg [M-H]- PIS 
Dimethyl-
ethanolaminephosphate 168.108202 Brugger1997 
 
Table 5. Exact mass values of Product Ion and Neutral Loss Scan experiments. SM, Sphingomyelin; 
GPCho, Glycerophosphatidylcholine; GPEtn, Glycerophosphatidylethanolamine; GPIns, 
Glycerophosphatidylinositol; GPSer, Glycerophosphatidylserine; CE, Cholesteryl ester; MG, 
Monoacylglycerol; DG, Diacylglycerol; GPGro, Glycerophosphatidylglycerol; GPA, 
Glycerophosphatidic acid; Pos, Positive ionization mode; Neg, Negative ionization mode; NLS, Neutral 
Loss Scan; PIS, Parent Ion Scan; Busik2009, (Busik et al., 2009); Han2005, (Han & Gross, 2005); 
Han1995, (Han & Gross, 1995); Brugger1997, (Brugger, Erben, Sandhoff, Wieland, & Lehmann, 1997). 
 
Given that the presence of certain Product Ions of Neutral Loss can only suggest that 
the identity of a precursor is any of a subset of lipid classes, the identification of 
different ions is essential, and the more ions sustaining the same classification the more 
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likely the molecule was correctly assigned. As an example, the spectra from a precursor 
could contain an ion signal at an m/z=184.150662 which would suggest that the 
precursor is either a Sphingomyelin (SM) or a Glycerophosphatidylcholine (GPCho), 
and this is because both lipid classes can produce a Phosphocholine group that can be 
lost in an ion form. Thus, it would be necessary the identification of a Product Ion or a 
Neutral Loss that is exclusive for a SM and not for a GPCho, as it is the case of the 
Dimethyl-ethanolaminephosphate. The function neutralLossScanner.R will search for 
the listed Product Ions as well as ions resulting from the subtraction of the precursor 
m/z and the Neutral Loss values in the spectra generated in the MS/MS experiments. 
The hits will be stored and compared to identify either contradictions of confirmations 
for the assigned lipid class. 
Finally, a list of lipid classes and associated frequencies will be reported for each 
precursor, this is expected as a single precursor can be measured several times in the 
Tandem MS experiment due to different elution times. 
As it is possible that two lipids corresponding to different lipid classes have the same 
m/z value and, although much less likely, the same retention time, this is interrogated. 
This way a list of precursors with an unrelated second assigned lipid class is reported. 
Additional details related to the algorithm used for the identification of the Product Ions 
or the Neutral Loss indicated in the Table 5 are present in the Appendix B together with 
the full code. 
Figure 6 shows the general flux diagram of the designed pipeline for the lipid 





Figure 6. Flux diagram for the processing of Tandem MS data. Blue arrows: identification based on lipid 
libraries; red arrows: identification based on Product Ion (PIS) and Neutral Loss Scan (NLS) data. 
Yellow symbols indicate steps where reports are generated. White rectangle indicates parameters. Light 






Mass Spectrometry Data Processing 
Data obtained from four clinical samples of P. vivax were processed on an Agilent 6550 
iFunnel QTOF-MS. Positive and negative ionization modes were analysed to obtain the 
m/z values corresponding to monoisotopic features being either statistically significant 
up or down expressed in P. vivax infected human cord blood reticulocytes when 
compared to non-infected reticulocytes coming from the same initial cell culture. The 
R-based pipeline used to identify those candidates is described in the Materials and 
Methods section and graphically depicted in Figure 5, the full code can be found in the 
Appendix B. The biological samples were processed in two different experiments. In 
the Experiment 1 the cell count was obtained and used to determine the input volume 
for the mass spectrometer. For the Experiment 2, the protein content was used to 
determine the input volume for the mass spectrometer. A detailed description of the 
data is found in Table 3 and Table 4 as well as in the Material and Methods section. 
The error rate was calculated per set of technical replicates, in all the cases the 
proportion of features that had all the replicates a value either above or below the 
threshold of 5,000 counts was higher than 93.6%, Figure 7, S1, S2 and S3 show the 
percentage of reproducible features for the Experiment 1 and Experiment 2 in positive 




Figure 7. Reproducibility in feature detection in the Experiment 2 in positive mode. 
 
Evaluation of Normalization methods for Non-Targeted Mass 
Spectrometry Data 
Due to the absence of cell count data for the Experiment 2, six normalization methods 
were tested in order to compare the samples: 
- ‘Quantile Normalization’. This is commonly used in microarray analysis and it 
is based on the idea that a straight line in a quantile-quantile plot of two 
distributions will indicate that they are the same, thus, it makes each sample 
to have the same quantiles (Bolstad et al., 2003). 
- ‘Total Sums’. Assuming that the same lipid content is present on each sample 
including those infected with the malaria parasite, the total sum of intensities 
per sample should be the same. 
- ‘Median fold normalization by sample’. It centers each distribution in the 
median of the fold changes where the median values come from the samples. 
This idea came out as a slightly modified version of the following widely used 
method but here assuming that the large number of lipids will make the global 
lipid expression per sample similar. 
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- ‘Median fold by feature’. As already mentioned, it centers the distribution of 
intensities in the median fold of the fold change calculated by feature, this 
follows the idea and code reported in a metabolic study using UPLC-MS 
(Veselkov et al., 2011). 
- ‘Median fold (limma)’. It also makes each distribution to have the same 
median, this method was proposed by (Smyth, 2005) to work with microarray 
data and it is now the standard for this kind of data. 
- ‘Protein estimation’. It assumes that the protein content in infected and non-
infected cells remains the same, then the estimated protein content is used to 
normalize the sum of the intensities per sample. 
 
In an attempt to evaluate which normalization procedure was the best for the present 
data, all these methods were tested. As mentioned in the Materials and Methods section, 
there is no consensus on the best method to assess the validity of the normalisation 
process, therefore some ideas were borrowed from tried and tested microarray or 
metabolomic protocols (Bolstad et al., 2003; Smyth, 2005; Veselkov et al., 2011). 
Following the idea that a normalization procedure should reduce the standard deviation 
(SD) of the measurements between samples coming from the same type (i.e. infected 
or not infected), the boxplots in Figure 8 intend to show the compression of the SD as 
a result of the different methods. While the ‘median fold normalization by sample’ 






Figure 8. Boxplots of the standard deviations (SD) for each m/z value observed separated by conditions 
(infected (Pv) or not infected (Retics)). For the ‘total sums’ and ‘protein estimation’ methods a different 




Given that technical replicates should show variation due to noise during the 
measurements, an effective normalization method should group them together, Figure 
9 shows that only normalization by protein estimation gets this clustering.  
Finally, a more common way to evaluate the improvement of a normalization method 
is the usage of a multiparametric analysis (J. Lee et al., 2012; Veselkov et al., 2011). 
Here, the six methods as well as the original data were evaluated with PCA (using the 
function prcomp() from the stats package in zero centered mode), inspecting the 
clustering of the technical replicates by observing the plots of the first and second 
principal components they show that the normalization by ‘protein estimation’ clusters 
the non-infected samples all together while infected samples get grouped by clinical 















Figure 9. Plot of the median values of the intensity for each of the samples using the six normalization 
methods and the not normalized data (‘Not Norm.’). Plotting the median helps choosing a feature 
behaving in a common fashion, avoiding considering a contamination metabolite or an artefact. Green, 
blank; red, infected samples; blue, non-infected cells. The order in the X-axis is the following: blank 
replicate 1 (r1), blank replicate 2 (r2), Pv1 r1, Pv1 r2, Pv3 r1, Pv3 r2, Pv5 r1, Pv5 r2, reticulocytes r1, 







































































































Figure 10. Principal component analysis original and normalized data by protein estimation using the 
data for the positive mode. X-axis, principal component; Y-axis, second component. Green, non-infected 
samples; blue, infected samples. 
 
 
Identification of Ions Differentially Present 
By using the normalized data by ‘protein estimation’, the pipeline described in the 
Materials and Methods section was used with the data from the Experiment 1 and 
Experiment 2 in positive and negative modes. Figure 11 and Figure S9 depict the flux 
diagram of the filtering protocol that was followed to distinguish the statistically 
significant monoisotopic features in positive and negative modes, respectively, 
including the different numbers of filtered features at each step. A total of 160 features 
were predicted as monoisotopic candidates being more abundant in P. vivax-infected 
human reticulocytes than in non-infected cells from the same type (p-value≤0.05, 
Student’s t-Test), while 76 were less abundant (p-value≤0.05), considering the positive 
and the negative mode together. Only one feature was identified as di-protonated. Table 
6 shows the number of predicted monoisotopic features for each mode, condition and 
experiment. These features made up the candidates for the MS/MS experiment. 
 
 
3 Pv clinical samples (Pv1, Pv3, Pv5), 
in duplicate 
1 Reticulocyte sample (Retic), in 
triplicate 
1 Negative control (blank) 
Normalized by 
protein content 
1.5x in Pv compared to 
Retics (p-value ≤ 0.05) 
Filtering by retention time 
value ([3, 14] mins) 










Filtering the mono-isotopes 
363 UP in Pv, 
123 UP in Retic 
25 UP in Pv, 
28 UP in Retic 
113 UP in Pv 
35 UP in Retic 2 UP in Pv, 
8 UP in Retic 








Table 6. Summary of the number of candidates being more abundant in infected (P. vivax) or not (CB 
Reticulocytes) in each mode and separated by experiment (p-value≤0.05, Student’s t-Test). 
 
To assess if choosing a different normalization method would give a different set of 
candidates, the whole pipeline was run for the six normalization methods as well as 
with the raw (original) data and the overlapping was calculated. Table 7 shows that a 





Table 7. Comparison of the number of features predicted by using different normalization methods and 
the original data for the positive ionization mode. UPPv, up regulated or more abundant in the infected 
samples; UPRetic, more abundant in non-infected samples. The square brackets indicate pairs of 
compared sets that either share an intersection with the depicted number of elements on it or that are one 
contained in the other, for example, the intersection of the Quantile normalization UPPv and Fold change 
using limma package contains 99 elements and this last set is fully contained in the protein estimation 
set. 
 
Further analysis of the candidates revealed that there is a difference of 18 features that 
are not considered as significant more abundant in the malaria samples when the 
pipeline is run without any normalization procedure in the positive ionization mode 
(see Table 7). In order to understand why some features are eliminated by the 
normalization by Protein Estimation, that otherwise would remain in the list of 
candidates if no normalization procedure was used, 10 random m/z values 
corresponding to the set of candidates obtained when using protein estimation and 
another 10 random m/z values from the set of 18 candidates being only predicted when 
no normalization method is used were selected to compare the median of their intensity 
values. Figure 12 shows in the upper row the 10 chosen m/z values that were only 
obtained when no normalization was applied (eliminated) and in the lower row the 10 
chosen m/z values obtained after either normalization by protein estimation or no 
normalization. The two plots at the left show the intensity values before normalization 
and at the right after normalization by protein estimation. The colors of the open circles 
indicate if the sample is a blank (red), a P. vivax-infected reticulocyte (blue) or a non-
infected reticulocyte (green). Lines connect measurements with the same m/z. In the 
plots it can be observed that at least one feature from the ‘eliminated’ set behaves more 
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irregularly even after the normalization while the behaviour of the 10 selected features 
in the ‘common’ candidates is more homogeneous and a clear difference is observed 
with respect to the non-infected samples. This indicates that the normalization by 
Protein Estimation is correctly eliminating features that do not have a homogenous 
pattern of differencial intensity between infected and non-infected samples. 
 
 
Figure 12. Comparison of the distribution of intensities for specific m/z values before and after 
normalization by protein estimation. Upper row, ten randomly selected m/z values followed in the 
different samples (red lines) corresponding to predicted candidates when the not normalized data was 
used but not predicted when protein normalization was used; lower row, ten randomly selected m/z 
values corresponding to predicted candidates in both not normalized and normalized by protein 
estimation; left column, the intensity values before normalization; right column, intensity values after 
normalization by ‘protein estimation’. The colour of the circles indicates: red, blank; blue, infected 
samples; green, non-infected samples. Circles joined by the red line represent features with the same m/z 
value in different samples. 
 
For the presented reasons, the normalization method based on ‘Protein Estimation’ was 
selected as the best procedure to reduce the variation due to factors that are irrelevant 
with regard to the infection process, such as the variations in the lipid extraction of the 
detection of the instrument, and it was applied to the samples from the Experiment 2 
from both infected and non-infected cell samples. Figure 13 and Figure S10 show a 
sum up of the 236 candidates identified in both Experiments in positive and negative 
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ionization modes, respectively. 42 of those features (26% of the ions overrepresented 
in P. vivax-infected samples) were absent in the signals obtained in the non-infected 
samples. The list of the 236 candidates was used for a Tandem MS experiment. 
 
 
Figure 13. Distribution of the candidates for MS/MS in positive mode. The solid blue symbols denote an 
infinite fold change obtained when no signal existed in the non-infected sample. 
 
Tandem Mass Spectrometry Data Processing 
The list of candidates obtained from the MS analysis was used for Tandem MS on an 
Agilent 6550 iFunnel QTOF-MS in both positive and negative ionization modes using 
the same lipid extraction from the samples of the Experiment 2 as in the MS 
experiments. The QTOF-MS generated mgf files that correspond to the input data for 
the following analysis. 
More than 32 thousand spectra were detected but less than 5% of them had a similar 
retention time with the initial measurement obtained during the MS experiment. A 
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window of 30 seconds was used to compensate technical errors, Table 8 describes the 
raw and filtered data. 
Table 8 
Condition UP in infected reticulocytes UP in non-infected reticulocytes 
Ionization Mode Positive Negative Positive Negative 
MS/MS output 11,271 11,173 4,859 4,843 
Filtered by Retention Time 574 530 237 236 
Hits with MS/MS libraries 57 281 9 26 
Precursors with assigned LC 15 66 3 9 
Mode/Adduct clustering 39 8 
 
Table 8. Summary of the number of spectra obtained from the Tandem MS experiment (MS/MS output) 
and after filtering the spectra with Retention Times that do not coincide with the time reported during the 
MS experiment (a margin of 30 seconds is used to tolerate technical errors). ‘Hits with MS/MS libraries’ 
refer to the number of hits retrieved with MSPepSearch in high-throughput mode. ‘Precursors with 
assigned LC’ describes the hits with non-ambiguous assigned Lipid Class. The number of different 
precursors regardless the mode or adduct measured is shown in the last row. 
 
Lipid Identification by Library Search 
The filtered mgf files were processed with the NIST software MSPepSearch for high-
throughput search of spectra corresponding to a reported lipid within a library. The 
computer-generated LipidBlast database was used as target and the results were merged 
with other smaller custom libraries for specific lipid classes like Cer, CE, 
Lysophosphatidylcholines, Phosphatidylcholines, SMs and Lyso-PAs (Kind et al., 
2013), as described in the Materials and Methods section. 
The hits produced by this tool (373 counting all the filtered spectra and including 
possible multiple hits from the same query) are, afterwards, processed in order to 
eliminate low quality hits (based on the reverse dot product calculated by the 
MSPepSearch software) or queries whose assigned lipids were discordant at the lipid 
class level between the spectra with the same precursor and exactly same retention time 
(which means that the same query was assigned ambiguously). When the lipid class is 
concordant but the subclass or the distribution of carbons in the acyl chains is 
discordant, the shared (concordant) information is kept. 
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To take advantage of the information contained between the two ionization modes, 
lipids assigned to precursors in more than one mode are identified. To perform this, a 
clusterization method was developed. The subclass, total number of carbons, total 
number of double bonds and the distribution of carbons and double bonds in the acyl 
chains of the hits with the same m/z value (or with a difference equal or less than 0.02 
units in the m/z value) are compared. At this point the information of the adduct will 
also be used, to give chance that one spectra had a hit with a different adduct, hence, 
having different hits the same retention time and m/z. In the case a second hit has the 
same mode and adduct, one of them is eliminated as no additional information will be 
provided (that was just a case of a delay in the elution of the lipid compound in the LC 
column). On the other hand, if a second hit is found coming from a different mode or 
adduct this is reported as it is a stronger confirmation of the identity of the lipid. In the 
case of the P. vivax-infected and non-infected data, no second hits were obtained, 8 and 
39 different precursors from the non-infected and the P. vivax-infected set were 
assigned to a lipid class, respectively (47 spectra when including assigned lipids in 
different modes or adducts). An individual mgf file was generated for each one of these 
spectra. 
Once the large number of initial measurements was narrow down to up to 0.15%, a 
manual curation of the hits was performed using the graphical user interface of 
MSPepSearch to verify the concordance of the peaks in the MS/MS spectra and the 
reported peak distribution in the different libraries. The exclusion criteria included the 
deletion of hits where one or both of the acyl chains did not have a match or if it could 
be ambiguously assigned to a second lipid species. An example of the match found 
between the obtained spectra and the library is shown in Figure 14, where the four most 
abundant peaks of the spectra at precursor m/z=816.5769 [M-Ac-H]- and retention time 
8.80 min had perfect match with GPCho(16:0/18:2). The peaks corresponding to the 
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fragments with masses 742.5386, 279.2322, 255.2322 can be observed in Figure 14 
and are also listed in the last column of Table 9. 
 
 
Figure 14. The spectra obtained from the MS/MS experiment at m/z=816.5769 and retention time 8.80 
min (top) matched the spectra of GPCho(16:0/18:2) (bottom). The structure of the lipid with the double 
bonds in an arbitrary position is also depicted. 
 
A total of four MS/MS spectra were unambiguously assigned to lipid species within 
the sample group corresponding to non-infected reticulocytes while nine were assigned 
within the sample corresponding to P. vivax-infected reticulocytes. The identified lipids 
are listed in the Table 9. Interestingly, two of the assigned precursors where not 











836.5442 8.34 GPSer(18:0/22:5) 749.5121, 483.2513, 465.2407 
810.5298 7.97 GPSer(20:4/18:0) 723.4964, 457.2356, 439.2251 
834.5294 7.93 GPSer(18:0/22:6) 747.4964, 481.2356, 463.2251 




816.5769 8.80 GPCho(18:2/16:0) 742.5386, 279.2322, 255.2322 
864.5752 8.53 GPCho(20:4/18:2) 790.5386, 864.5754, 303.2322 
830.5917 9.52 GPCho(18:0/18:2) 770.5699, 830.5911, 283.2635 
758.5849 8.77 GPCho(16:0/18:2) 184.0738, 758.5699, 699.4964 
892.6052 9.48 GPCho(18:0/22:6) 818.5699, 892.6067, 305.2479 
840.5775 8.71 GPCho(20:4/16:0) 766.5386, 840.5754, 279.2322 
794.6160 9.51 PC(P-18:0/20:4) 526.3298, 508.3768, 467.2563 
575.5221 7.68 DG(16:0/16:0/0:0) 263.2560, 575.5223, 337.2928 
844.6084 9.04 GPCho(18:0/18:2) 844.6068, 770.5699, 283.2635 
 
Table 9. Identified lipids by MS/MS analysis. Four and nine lipid species were identified in the MS/MS 
data from the non-infected and P. vivax-infected reticulocytes, their m/z value and retention time are also 
shown. The last column indicates the first three most abundant fragments used to identify the lipid. 





Figure 15. The identified lipids in from the MS/MS experiment. Nine and four lipids were identified in 
the P. vivax-infected and non-infected reticulocyte samples, respectively. Their m/z value and fold 
change as found in the Experiment 2 are illustrated. In the case of DG(16:0/16:0) and GPCho(18:0/18:2), 
that were not identified in the non-infected samples, they are drawn at an arbitrary position. 
 
Lipid Identification by Product Ion and Neutral Loss Data 
In order to expand the search for possibly new lipids within the analysed samples, a 
broader search was performed by looking at ions that are characteristic of certain lipid 
species. For example, the loss of phosphocholine is common after the fragmentation of 
SM or GPCho, the sodium cholinephosphate is only characteristic for GPCho 
fragmentation spectra and the phosphoetanolamine is generated only when a GPEtn is 
processed in MS/MS. Thus, a list of the masses of ions and neutral molecules that are 
commonly generated after fragmentation of lipids was collected as described in the 
Materials and Methods section. These values are used by a new algorithm to identify 
the possible lipid class for the different filtered spectra corresponding to the analysed 
samples. Table 10 summarizes the different precursors assigned to a single Lipid Class 
and some that remain ambiguous. It is worth noting that some classes where exclusively 
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found in one or the other sample. Tables S2 and S3 show the m/z values of the 
precursors and its corresponding assigned class as well as the ‘Supporting value’ which 
indicates how many times the same precursor was assigned to more than one Product 
Ion or Neutral Loss corresponding to a different Lipid Class because it was identified 
in different ionization modes or a different retention times. 
  





SM 2 0 
GPIns 1 1 
GPSer 6 2 
GPEtn 1 8 
GPA 0 2 
CE 1 0 
MG, DG 3 5 
SM, GPCho 3 15 
Gro, GPA 0 2 
Total 17 41 
Ambiguous 0 6 
 
Table 10. Number of precursors identified at the Lipid Class level by Product Ion and Neutral Loss data-
based assigning. When the same precursor was assigned to more than one Product Ion or Neutral Loss 
corresponding to a different Lipid Class it was considered as ‘Ambiguous’. SM, Sphingomyelin; GPCho, 
Glycerophosphatidylcholine; GPEtn, Glycerophosphatidylethanolamine; GPIns, 
Glycerophosphatidylinositol; GPSer, Glycerophosphatidylserine; CE, Cholesteryl ester; MG, 




Tracking of Identified Lipids 
The identified lipid species were sought within the data from the Experiment 1 as a 
proof of principle of the useful combination of information collected from different 
experiments. Figure 16 shows that different behaviours can be observed in different 
maturation stages of erythrocytes and with different Plasmodium-infected samples. 
These results should be taken with caution as they correspond to a single experiment 
that requires further validation. Therfore, they can be inconsistent with the observed 
patterns from the lipid extractions from the clinical samples (Experiment 2) as observed 
in the two identified lipids over represented in the non-infected samples from the 
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Experiment 2 that did not show the same abundance ratio in the Experiment 1 (see 




Figure 16. Tracking of the identified lipids being over-represented in the P. vivax-infected samples as 
found in the Experiment 2 in the data from Experiment 1. Two different behaviours can be observed, 
similar abundance in P. falciparum-infected sample as in the non-infected reticulocyte (a) and higher 
abundance in P. falciparum-infected sample when compared to non-infected reticulocytes. In the X-axis, 
the samples are as follows: P. vivax-infected reticulocytes, non-infected reticulocytes, P. falciparum-







In the presented work three contributions can be highlighted, (i) a robust (the 
implementation can capture several errors in order to prevent the program to die) and 
flexible (it is possible to use different number of samples and controls as well as blank 
samples, all parameters can be easily adjusted in the running line and sub-routines can 
be prevented to be executed if desired) pipeline for the analysis of MS and Tandem MS 
data was developed for their easy use in R language with the option to receive the very 
raw data generated by the mass spectrometers to perform the whole analysis in a 
reproducible manner preventing many possible technical details that could face the 
analysis, such as different number of samples per condition, variations in retention 
times between the MS and the MS/MS experiments or the presence of multiple lipid 
classes having the same m/z and retention time. It is also able to be adjusted at different 
times of the analysis, for example, it can receive different number of samples per 
condition, including ‘blank’ samples that can measure the level of noise in the mass 
spectrometer. The width of the window for the m/z, retention time values, the 
percentage of samples expected to have an up or down expressed feature in order to be 
considered as a true differentially expressed ion and many other parameters can be 
modified depending on the kind of instrument used or the comparison intended to be 
done. This implementation is only dependent on two R packages: xcms and limma and 
the MSPepSearch tool, being the rest newly generated code. 
(ii) In terms of the malaria field, the design of the pipeline allows the correct 
comparison of unique samples with their correct control. Given the particular 
preference of P. vivax parasites (and most likely total dependence) for reticulocytes 
(Kitchen, 1938), it stands out the importance of using non-infected reticulocytes as the 
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control for the infected cells, instead of the heterogeneous red cells. All this, without 
losing the track of the identified molecules in a control cell group of uninfected red 
blod cells (uRBC) and in other Plasmodium species (as in this case, the Pf1 and Pf2 
samples). 
Finally, (iii) the congruent findings with the reviewed literature represent the proof of 
concept of the efficacy of this pipeline and give an idea of the sensitivity that can be 
obtained by working with untargeted MS and Tandem MS experiments with lipid 
extractions from malaria infected samples and their controls. 
 
The identified lipids 
This is the first approach reported so far trying to characterize the differences in the 
lipid composition of the reticulocytes before and after the infection with P. vivax. 
Although quite reduced in the number of samples to reliably probe the metabolization 
or the synthesis of particular lipid species, this initial observations suggest the 
metabolization of some GPSer molecules to GPCho. Seven out of the nine identified 
lipids significantly over represented in the P. vivax-infected samples corresponded to 
GPCho lipids with 16 to 22 Carbons in the fatty acyls having from zero to six double 
bonds. The over-representation of GPCho in the identified metabolites is in agreement 
with the described enrichment of the same molecule in P. falciparum, that together with 
GPEtn make up around 80% of the GPLs (Elabbadi, Ancelin, & Vial, 1997) and more 
recently it was found as enriched in the apicoplast (Botté et al., 2013). It has been shown 
that pathways for the synthesis of GPCho are functional in Plasmodium, one using 
GPSer and a second one via the decarboxylation of Serine to Ethanolamine, being the 
first one the preferred route in P. falciparum  and P. knowlesi, at least (Elabbadi et al., 
1997). This should explain the disappearance or depletion of GPSer molecules like 
GPSer(18:0/22:5), GPSer(20:4/18:0) and GPSer(18:0/22:6) from the non-infected 
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reticulocytes. The contrasting observations from the Experiment 1 do not represent a 
contradiction as it corresponds to a single analysed sample (Figure 16 and S11). 
Additionally, (Botté et al., 2013) also reported DG(32:0) as a molecule present in P. 
falciparum and being enriched in the apicoplast of this parasite species which here it 
was identified as DG(16:0/16:0), abundant in the infected samples but not detected in 
the non-infected cells. An alternative pathway for the production of DG is through the 
conversion of GPCho with the addition of Cer, this reaction will also lead to the 
production of SM (Mitamura & Palacpac, 2003) which could not be detected in this 
study. 
These initial results are in agreement with the reported lipid composition of 
erythrocytes infected with P. falciparum, however the accumulation of certain lipids 
can be totally different when studying infected reticulocytes as this early erythrocyte is 
more metabolically active (Goh et al., 2007; E. Lee et al., 2014) and its own lipid 
metabolism can compensate or exacerbate the lipid changes product of the infecting 
parasite. 
The difference in the host cell used for invasion in P. vivax and P. falciparum should 
implicate a different initial phospholipid material to be used by the parasite in case 
there is any variance. It is known that the lipid metabolism in the normocyte is almost 
non-functional (van Deenen & de Gier, 1974) so any change observed after the 
infection starts can be attributed to the parasite metabolism, this, however, is not the 
case when the young and metabolically active reticulocyte (Goh et al., 2007; E. Lee et 
al., 2014) is infected. This is why any well designed study should consider the 
generation of data from reticulocytes, normocytes and the same cell cultures now 
infected. For the presented master thesis, the correct comparison of the infected cord 
blood reticulocytes and a never infected cord blood reticulocyte cell culture was 
studied. This skips the common use of direct human blood extractions given the 
difficulty to get pure P. vivax cultures. 
52 
 
Understanding the contribution of each of the parts could help deciphering, for 
example, (i) what are the essential differences that confer different tropisms for each 
species and (ii) in giving new hints on how to maintain an in vitro culture of P. vivax. 
For example, a synthetic analogue of Choline (G25) has been shown to have an 
inhibitory activity for the in vitro growth of P. falciparum and in vivo activity of P. 
falciparum and P. chabaudi without adverse effects in mammalian cell cultures. 
Interestingly, this compound also showed activity against P. vivax and P. cynomolgi in 
vitro assays, both species can only invade reticulocytes indicating that there are no 
compensatory mechanisms in the metabolism of this host cell preventing the 
antimalarial activity of G25 (Wengelnik et al., 2002). 
It is worth mentioning that the four identified lipids being overrepresented in the non-
infected reticulocytes had a significant, although low, intensity in the P. vivax-infected 
samples. This situation suggests a slow degradative process by the parasite or an active 
process in the infected reticulocyte that maintains the phospholipids at detectable 
levels, probably because of an essential function for the membrane stability of the 
erythrocyte making their lost not permissible. However, this could also indicate an 
under identification in the non-infected samples. 
One of the only two molecules that could not be detected in the non-infected sample 
but observed and identified in the infected one was the DG(16:0/16:0). Although this 
molecule has been detected and quantified in blood samples from healthy human adults 
(J. Lee et al., 2012), the full biosynthetic pathway is present in P. falciparum , which 
contains the Glycerol-3-phosphate O-acyltransferase (G3PAT or GAT, also named 
Acyl transferase I in humans) that catalyses the first acylation of Glycerol-3-phosphate 
to generate Lyso-PA. Then, 1-Acyl-sn-glycerol-3-phosphate O-acyltransferase 
(LPAAT, also named Acyl transferase II in humans) transfers a second acyl group to 
produce Phosphatidic acid, which is de-phosphorylated by Phosphatidate 
cytidylyltransferase (CDS) to produce DG. 
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As mentioned, there are two enzymes with acyltransferase activity with glycerol-3-
phosphate as a substrate, they are G3PAT, encoded in the chromosome 13 of P. 
falciparum but functional in the Apicoplast (Lindner et al., 2014). The second enzyme 
is called GAT, encoded in chromosome 12 and functional in the Endoplasmic 
Reticulum (ER) membrane (Santiago, Zufferey, Mehra, Coleman, & Mamoun, 2004). 
The enzyme transferring the second acyl group is named LPAAT, found in the 
chromosome 14 of P. falciparum and active in the ER. G3PAT, GAT, LPAAT and 
CDS have all predicted homologues in P. vivax as reported in PlasmoDB, suggesting a 
conserved metabolism in both species. 
For the case of GPCho(18:0/18:2), it has been detected and quantified in urine and it is 
predicted to be present in all tissues. Moreover, GPCho(36:2) has been reported as 
highly abundant in human blood plasma (Quehenberger et al., 2010) but no more details 
have been published about their presence in reticulocytes. 
Galactolipids have been reported in Toxoplasma gondii and in P. falciparum (Marechal 
et al., 2002). Although LipidBlast computationally modelled spectra from more than 
16,000 lipids corresponding to Mono- and di-galactosyldiacylglycerols as well as 
Sulfoquinovosyldiacylglycerols, none of the studied candidates produced a hit against 
these lipid classes. 
The approach used to look for the presence of lipid classes by looking at particular ions 
that are specific for certain lipid classes was described before in a study of the lipids in 
rat retinal tissue (Busik et al., 2009). Although less accurate than the full spectra match, 
the results again showed a higher abundance of SM/GPCho lipids, as measured by the 
presence of phosphocholine and other molecules that can appear in the degradation of 
either SM or GPCho (see Table 5). However, dimethyl-ethanolaminephosphate, a 
marker for SM was never detected in P. vivax infected cell, suggesting that the 
SM/GPCho molecules were actually GPCho, confirming the enrichment observed in 
the identified lipids. The database used for Product Ion and Neutral Loss Scan was quite 
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reduced but the code that do the scanning from the MS/MS data showed its successful 
functionality at merging information obtained from more than one hit, different Scan 
modes and ionization modes. More ions have been described as signatures for lipid 
class identification but they lack resolution (See Table S1), as many of them are 
described by their nominal masses (when the masses of the atomic constituents are 
taken as integers), all these low-resolution cases were not considered for the presented 
results. 
Lipidomics in Malaria Research 
Although the sample number is relatively small, it represents the first study performed 
on short-term in vitro culture of P. vivax by using Cord Blood reticulocytes, an 
important initial step in the correct characterization of the P. vivax infection process. 
Getting knowledge on the lipid composition could lead to different opportunities like: 
the inhibition of a new exclusive metabolic pathway in plasmodium, the identification 
of targets for the development of antibodies anti-lipids in a similar way as it was done 
for species-specific mycolic acids as an alternative to Tuberculosis diagnosis (Chan et 
al., 2013), to accelerate the diagnosis and reduce the misdiagnosis hence, improving 
the monitoring of malaria infections which is many times underestimated as it was 
revealed in a study of asymptomatic cases of vivax malaria in Cameroon (Fru-Cho et 
al., 2014) and in Malaysia with P. knowlesi (Yusof et al., 2014). And finally, and as a 
more ambitious perspective is that a P. vivax-specific lipid in the plasma membrane of 
the host reticulocyte could be used for the administration of a monoclonal antibody to 






The programming language used is R (v.3.0.2), which is widely used and is commonly 
the preferred language by research groups working with biological data, in particular 
for high-throughput experiments. It allows a high degree of flexibility as it can be 
managed as a package with several independent functions that can take the data in or 
out at different points. The automation of the whole pipeline used here gives the 
warranty of the reproducibility of the results. 
XCMS (Smith et al., 2006) has become broadly used and a proof of its success is the 
publication of several improvements to either the feature detection algorithm 
(Tautenhahn et al., 2008) or the online version (Gowda et al., 2014) which is user-
friendly but less flexible to design ad hoc filtering and processing of the samples. For 
example, it does not allow (i) the exploration of normalization of the data, (ii) the 
elimination of represented features in a blank sample, (iii) the performance of statistical 
analysis based on technical replicates to eliminate non-reproducible features or (iv) 
further processing of data coming from two different experiments. These impediments 
could be overcome by producing a new pipeline that fulfils the requirements of the 
project. Moreover, the architecture of the designed pipeline can be useful for future 
characterization experiments from the P. vivax laboratory or other groups. 
In many lipidomics studies the usage of QC samples are used to evaluate the quality, 
the signal-to-noise ratio and the improvement obtained after a normalization procedure 
was done (Berg et al., 2013; Veselkov et al., 2011). In cases where no standards are 
used, as it is the case of untargeted MS experiments, it has been suggested to use as a 
QC sample the mixture of both the sample and the control, this way in a multivariate 
analysis like PCA, the different QC samples should group together, otherwise their 
significant spread would indicate noise and the presence of artefacts. However, due to 
the nature of the present project, the control sample is a subset of the ‘infected’ sample, 
as only 10.9 to 15.1% of the cells were P. vivax positive (as shown in Table 4) making 
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it senseless the use of QC samples. Here, the use of the information obtained from 
technical replicates was used to measure the improvement of the normalization 
methods. 
The evaluation of the normalization protocols is essential and must be done for every 
different experiment as the variations could come from different sources, as in this case 
that samples from Experiment 1 and Experiment 2 came from different protocols. In 
particular, for the aim of this project we are interested in relative changes and not in 
absolute levels. Lipidomics analyses do not give absolute numbers as it is the case of 
RNA sequencing data, however fold change can be assessed in a similar fashion as it 
has been done for RNA expression. 
Cell count should always be the best way to avoid problems with normalization but it 
is not always achievable as in this case where the protocol used to enrich P. vivax-
infected reticulocytes does not allow the cell counting. Furthermore, the use of 
parasitemia data is not meaningful here as non-infected samples are to be compared. 
Between the methods tested for normalization, two very similar approaches based on 
median fold change normalization were used. Based on (Veselkov et al., 2011) it was 
assumed that given a large number of metabolites, the overall behaviour should be 
centered in a global median and only few will be outside, being those ones the 
interesting ones. For (Robinson & Oshlack, 2010), whose work was done in RNA-seq, 
they suggested to use the median obtained by samples instead, anticipating differences 
in several molecules but not in the more general distribution of the samples. 
To choose the normalization method here, it was assumed that the majority of the 
features do not change (as the infected infected cells should retain housekeeping 
functions to allow the system to survive). However, we did not assume that the few 
ones that change do it in a conservative manner. Thus, we allowed the mean of the 
infected versus the not infected samples to change, selecting a normalization method 
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not based on median fold change. In other words, the preferred methods used on 
transcriptomics analyses were not selected based on a rational derived from the 
biological differences of the measured molecules. 
Doing a normalization by protein estimation the results were not far dissimilar to the 
ones obtained by working with ‘median fold by feature’ which only re-scales all the 
values by a fixed number for the whole sample, and it is also very similar to ‘total sum’ 
normalization just adjusting the total to as standardized value (the sum of the 
intensities). 
The lipidomics field face an additional problem that nucleic acids and proteins do not 
present: the absence of a reliable database for comparison of the obtained results. 
Current lipid databases are mainly filled with computational predictions which cannot 
contain all the possible options, hence leading to a number of missing assignations 
(Kind et al., 2013). 
It has to be noted that for the processing of MS/MS data, a filtering of the spectra by 
using the retention time is necessary, otherwise several spectra will be present with 
retention times that will not match the initial retention time measured during the MS 
experiment. As this value should be constant because it depends on the lipid class as 
well as the size of the molecule and the length of the acyl groups, the initial value 
(obtained in the MS experiment) is used to narrow down the spectra of the MS/MS but 
a tolerance window is used (30 seconds) to allow expected variations, in particular 
because both experiments were performed at different times. 
The reproducibility observed in the feature detection in the Experiment 1 and 
Experiment 2 was never below the 93% considering both ionization modes which 
indicates that the initial material had exceptional quality. Interestingly, less features 
were observed in the Experiment 1, that was expected as a different lipid extraction 
method was used, where the second allowed the purification of sterols in addition to 
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phospholipids (which were only detected in the first experiment). This difference in 
lipid extraction protocols could also explain why only 8 out of 13 identified lipids were 
found in the Experiment 1 while the rest was not. 
The presented code is also able to identify double charged lipids as it was the case of 
the feature in the positive mode of the Experiment 1 (see Figure 11) with m/z= 646.4755 
with additional peaks at m/z=645.9712 and one more at m/z= 645.4748 having 
differences of 0.5 as expected in a di-protonated molecule and in a 4:2:1 ratio. 
Unfortunately, no validation for this prediction was performed as the precursor 
corresponding to its monoisotope was not processed in Tandem MS. 
Table 11 summarizes the different analyses that can be done with the presented package 
when compared to the mentioned programs XCMS and XCMS Online. 
 
Table 11 





Use of blank samples to 
identify noise 
✓ NA ✓ 
Statistical tests based on 
technical replicates 
✓ × ✓ 
Visualization of peaks 
✓ 







✓ × × 






















Table 11. Summary of functions that are implemented in the developed package and their status in XCMS 





A robust and flexible R package was developed to fulfil all the requirements needed to 
identify ions being differentially abundant in a MS experiment and also to process the 
data generated by a Tandem MS experiment to identify reliable lipid species. This 
method can be applied to different data sets in an automatized and reproducible way. 
The protocol was tested on human cord blood reticulocytes infected or not with P. 
vivax. A decrease in GPSer and increase in GPCho species are in agreement with the 
known metabolic pathways in Plasmodium, indicating an accurate data processing that 
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Figure S1. Reproducibility in feature detection in the first experiment in positive mode. The order in the 
X-axis is the same as in Table 1. 
 
 
Figure S2. Reproducibility in feature detection in the first experiment in negative mode. The order in the 





Figure S3. Reproducibility in feature detection in the second experiment in negative mode. 
 
 
Figure S4. Principal component analysis for quantile normalization method using the data for the 
positive mode. X-axis, principal component; Y-axis, second component. Green, non-infected samples; 




Figure S5. Principal component analysis for total sum normalization method using the data for the 
positive mode. X-axis, principal component; Y-axis, second component. Green, non-infected samples; 
blue, infected samples. 
8  
Figure S6. Principal component analysis for median fold normalization method by sample using the data 
for the positive mode. X-axis, principal component; Y-axis, second component. Green, non-infected 




Figure S7. Principal component analysis for median fold normalization method by feature using the data 
for the positive mode. X-axis, principal component; Y-axis, second component. Green, non-infected 
samples; blue, infected samples. 
 
Figure S8. Principal component analysis for median fold normalization method following the function in 
the ‘limma’ package form Bioconductor (Smyth, 2005) and using the data for the positive mode. X-axis, 





Figure S9. Flux diagram including the number of filtered features in each step in the negative mode. 
 
 
Figure S10. Distribution of the candidates for MS/MS in negative mode. The solid blue symbols denote 





Figure S11. Tracking of the identified lipids being over-represented in the P. vivax-infected samples as 
found in the Experiment 2 in the data from Experiment 1. Any precursor can be tracked to observe its 
level of abundance in a different experiment. Different behaviours can be identified. In the X-axis, the 
samples are as follows: P. vivax-infected reticulocytes, non-infected reticulocytes, P. falciparum-infected 













Molecule Exact Mass Reference 
SM, GPCho Neg [M+Cl]- NLS CH3Cl 50.488 Busik2009 
SM, GPCho Neg [M+CH3OCO2]- NLS CH3OCO2H+(CH3)3N 135.1617 Busik2009 
SM, GPCho Neg [M+CH3OCO2]- NLS CH3OCO2+(CH3)3NCHCH2 161.1989 Busik2009 
SM, GPCho Pos [M+H]+ PIS Phosphocholine 184.150662 Han2005 
SM, GPCho Pos [M+Na]+ PIS Sodium cyclophosphane 147.022 Han1995 
GPCho Pos [M+Na]+ NLS Sodium cholinephosphate 205.1404313 Han2005 
SM, GPCho Pos [M+Na]+ NLS Neutral phosphocholine 183.150662 Brugger1997 
GPEtn Pos [M+H]+, M+Na]+ NLS Phosphoethanolamine 141.063 Brugger1997 
GPEtn Neg [M-H]- PIS 
Glycerol 
phosphoethanolamine 
derivative 196.0275 Han2005 
GPIns Neg [M-H]- PIS 
Dehydrated 
phosphoinositol 241.104602 Han2005 
GPIns Pos [M+NH4]+ NLS Phosphoinositol+NH3 277.166282 Busik2009 
GPSer Pos 
[M+H]+, 
[M+Na]+ NLS Phosphoserine 185.072 Busik2009 
GPSer Pos [M+Na]+ PIS Sodium phosphoserine 208.0617693 Busik2009 
GPSer Neg [M-H]- NLS Serine-H2O 87.0777 Han2005 
CE Pos [M+NH4]+ PIS Cholestane cation 369.3 Han2005 
MG, DG Pos [M+NH4]+ NLS H2O+NH3 35.0458 Busik2009 
GPGro Pos [M+NH4]+ NLS Phosphoglycerol+NH3 189.104222 Busik2009 
18:0-based 
ceramides 
Pos [M+H]+ PIS Sphinganine derivative 266 Busik2009 
18:1-based 
ceramides 
Pos [M+H]+ PIS Sphingosine derivative 264 Busik2009 
18:2-based 
ceramides 
Pos [M+H]+ PIS Sphingadienine derivative 262 Busik2009 
18:0-based 
ceramides 
Neg [M-H]- NLS 16:0 aldehyde 258 Busik2009 
18:1-based 
ceramides 
Neg [M-H]- NLS 16:1 aldehyde 256 Busik2009 
18:2-based 
ceramides 
Neg [M-H]- NLS 16:2 aldehyde 254 Busik2009 
PL Neg [M-H]- NLS Stearic acid (18:0) 284.2715 Brugger1997 
PL Neg [M-H]- NLS Oleic acid (18:1) 282.2559 Brugger1997 
PL Neg [M-H]- NLS Linoleic acid (18:2) 280.2402 Brugger1997 
GPA Pos [M+NH4]+ NLS NH3+H3PO4 115.025702 Busik2009 
GPGro, 
GPA Neg [M-H]- PIS 
Cyclic glycerophosphate 
derivative 153.058442 Han2005 
GPIns Neg [M-H]- NLS Inositol unit -H2O 162.14058 Brugger1997 
GPIns Neg [M-H]- PIS [H2PO4]- 96.9872 Brugger1997 
PL Neg [M-H]- PIS Inositol unit -H2O 162.14058 Brugger1997 
PL Neg [M-H]- PIS [H2PO4]- 96.9872 Brugger1997 
SM 
Neg [M-H]- PIS 
Dimethyl-
ethanolaminephosphate 168.108202 Brugger1997 
PL Neg [M-H]- PIS 14:0 fatty acid anion 227.2017 - 
MGDG, 
DGDG Pos [M+Li(Na)]+ PIS 
Li(Na)+galactose 
derivative 227 Han2005 
SQDG Neg [M-H]- PIS Galactose derivative 225 Han2005 
 
Table S5. Exact mass values of Product Ion and Neutral Loss Scan experiments. SM, Sphingomyelin; 
GPCho, Glycerophosphatidylcholine; GPEtn, Glycerophosphatidylethanolamine; GPIns, 
Glycerophosphatidylinositol; GPSer, Glycerophosphatidylserine; CE, Cholesteryl ester; MG, 
Monoacylglycerol; DG, Diacylglycerol; GPGro, Glycerophosphatidylglycerol; GPA, 
Glycerophosphatidic acid; PL, Phospholipid; MGDG, Monogalactosyldiacylglycerol; DGDG, 
Digalactosyldiacylglycerol; SQDG, Sulfoquinovosyldiacylglycerol; Pos, Positive ionization mode; Neg, 
Negative ionization mode; NLS, Neutral Loss Scan; PIS, Parent Ion Scan; Busik2009, (Busik et al., 











439.2818909 SM 1 - 
604.3875732 MG, DG 1 - 
804.5751343 SM, GPCho 1 - 
806.5330200 GPIns 1 - 
810.5297852 GPSer 1 - 
826.5799561 MG, DG 1 - 
827.7203979 MG, DG 2 - 
834.5294189 GPSer 2 - 
836.5441895 GPSer 1 - 
836.5783081 GPSer 5 - 
837.6919556 CE 1 - 
842.6392212 GPSer 3 - 
897.7047729 SM 2 - 
1024.6757813 SM, GPCho 1 - 
1042.2441406 SM, GPCho 1 - 
1091.2396240 GPEtn 1 - 
1397.8868408 GPSer 1 - 
Table S2. Precursors from the over represented ions in the non-infected reticulocytes sample with an 
assigned Lipid Class. The asterisk indicates the number of precursors with same m/z but different 
ionization mode or retention time that contained an ion corresponding with a Product Ion or the Neutral 
Loss that supported the assigned Lipid Class. When the same precursor was assigned to more than one 
Product Ion or Neutral Loss corresponding to a different Lipid Class the second assigned class is 
reported. SM, Sphingomyelin; GPCho, Glycerophosphatidylcholine; GPEtn, 
Glycerophosphatidylethanolamine; GPIns, Glycerophosphatidylinositol; GPSer, 
Glycerophosphatidylserine; CE, Cholesteryl ester; MG, Monoacylglycerol; DG, Diacylglycerol; GPGro, 

















610.5592041 MG, DG 2 - 
612.5740356 MG, DG 4 - 
625.5357056 SM, GPCho 1 - 
634.5590210 MG, DG 1 - 
638.5890503 MG, DG 2 - 
662.5881958 MG, DG 2 - 
692.5393677 GPA 1 SM, GPCho 
701.5739746 SM, GPCho 1 - 
703.5913086 SM, GPCho 1 - 
716.5391846 GPA 1 - 
718.5551147 GPA 1 - 
718.5886841 GPEtn 3 - 
720.6036987 GPEtn 1 SM, GPCho 
734.5853271 SM, GPCho 1 - 
738.5087891 GPEtn 1 - 
742.5795898 GPEtn 3 - 
744.5648193 GPEtn 1 SM, GPCho 
744.5753174 GPEtn 2 - 
758.5848999 SM, GPCho 1 - 
762.6159668 SM, GPCho 5 - 
766.5841675 GPEtn 6 SM, GPCho 
774.6490479 GPEtn 2 - 
786.5147705 GPEtn 1 - 
786.6156006 SM, GPCho 1 - 
788.5430298 GPEtn 1 - 
788.6213379 GPSer 1 SM, GPCho 
788.6354980 SM, GPCho 5 - 
794.6160278 GPEtn 4 SM, GPCho 
796.6001587 SM, GPCho 2 - 
806.5835571 SM, GPCho 2 - 
810.6148071 SM, GPCho 4 - 
812.6311646 SM, GPCho 3 - 
815.5678101 GPEtn 2 - 
820.6064453 GPSer 1 - 
824.5780029 GPGro, GPA 1 - 
830.5809937 SM, GPCho 1 - 
834.6127319 SM, GPCho 1 - 
836.6265259 SM, GPCho 1 - 
844.6638794 GPSer 1 - 
859.5316772 GPGro, GPA 1 - 
861.5485840 GPIns 1 - 
 
Table S3. Precursors from the over represented ions in the P. vivax-infected reticulocytes sample with an 
assigned Lipid Class. The asterisk indicates the number of precursors with same m/z but different 
ionization mode or retention time that contained an ion corresponding with a Product Ion or the Neutral 
Loss that supported the assigned Lipid Class. When the same precursor was assigned to more than one 
Product Ion or Neutral Loss corresponding to a different Lipid Class the second assigned class is 
reported. SM, Sphingomyelin; GPCho, Glycerophosphatidylcholine; GPEtn, 
Glycerophosphatidylethanolamine; GPIns, Glycerophosphatidylinositol; GPSer, 
Glycerophosphatidylserine; CE, Cholesteryl ester; MG, Monoacylglycerol; DG, Diacylglycerol; GPGro, 






Complete code of the developed R package used to analyse the data 
filterTechReps.R 
# To filter the technical replicates. The indicated proportion of the replicates must be above or 
under 
# the specified threshold. 
# The following function does not need the filterIntensity() filter. 
# The function must be run per each sample. 
## USAGE: todosPfyControls<-filterTechReps(todos, 9:10) 
filterTechReps<-function(tabla, replicates, intensity.cutoff=5000, techRep.cutoff=0.66){ # 
Must be used 0.66 because 0.67*3=2.01 
 vector<-apply(tabla, 1, function(linea){ 
  # First case: replicates have an intensity above the cut off. 
 
 if(sum(linea[replicates]>=intensity.cutoff)>techRep.cutoff*length(replicates)) 
   return(TRUE) 
  # Second case: replicates have an intensity under the cut off. 
  else 
if(sum(linea[replicates]<intensity.cutoff)>techRep.cutoff*length(replicates)) 
   return(TRUE) 
  # Third case: replicates are inconsistent on being above or under the cutoff. 
These features 
  # will be eliminated. 
  else{ 
   return(FALSE) 






# This fuction normalize the Feature Intensities from an xset comming either from xcmsSet(), 
retcor(), 
# groups() or fillPeaks(), (an xcmsSet object). 
# USAGE: normalized<-featureNormalization(xset3, method="quantile", 
blank.columns=c(9:10)) 
featureNormalization<-function(xset=xset, method="quantile", blank.columns=NULL){ 
  xsetTable<-peakTable(xset) 
  classinfo<-attributes(xset)[5][[1]] 
  unique_classes<-unique(classinfo) 
  num_classes<-dim(unique_classes)[1] 
  columns<-as.numeric(7+num_classes) 
  columns1<-columns+1 
  meta<-data.frame(xsetTable[,c(1:columns)]) 
  # Columns corresponding to Blank samples are not considered for the normalization. 
  intensity.columns<-setdiff(c(columns1:ncol(xsetTable)), blank.columns) 
  originalIntensities<-xsetTable[,intensity.columns]   
  if(method=="quantile"){ 
    QnormalizedIntensities<-normalizeQuantiles(originalIntensities) 
#    colnames(QnormalizedIntensities)<-colnames(originalIntensities) 
    QnormalizedIntensities<-data.frame(QnormalizedIntensities) 
#    output<-cbind(meta, QnormalizedIntensities) 
    normalizedIntensities<-QnormalizedIntensities 
  } 
  else if(method=="totalsum"){ 
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    normalizedIntensities<-apply(originalIntensities, 2, function(sample){ 
      return(sample/sum(sample)) 
    }) 
    normalizedIntensities<-data.frame(normalizedIntensities) 
#    output<-cbind(meta, normalizedIntensities) 
#    normalizedIntensities<-t(apply(normalizedIntensities, 1, unlist)) 
  } 
  else if(method=="medianfold.sample"){ 
    # This method centers each distribution in the median of the fold changes. 
    # Method based on LB idea, obtaining the median values per sample. 
    # Replacing ceros for 0.0001 to avoid NaN or Inf values. 
    originalIntensities<-apply(originalIntensities, 2, function(x){ 
      x[which(x==0)]<-1 
      return(x) 
    }) 
    average<-apply(t(originalIntensities), 1, median) # Changed to median NOT as suggested by 
LB 
    foldpersample<-sapply(1:dim(originalIntensities)[2], function(index){ 
      return(originalIntensities[,index]/average[index]) 
    }) 
    mfnormalizedIntensities<-t(sapply(1:dim(originalIntensities)[1], function(index){ 
      return(originalIntensities[index,]/mean(foldpersample[index,])) # Changed to mean NOT 
as suggested by LB 
    })) 
    colnames(mfnormalizedIntensities)<-colnames(originalIntensities)  
    mfnormalizedIntensities<-data.frame(mfnormalizedIntensities) 
#    output<-cbind(meta, mfnormalizedIntensities) 
    normalizedIntensities<-mfnormalizedIntensities 
  } 
  else if(method=="medianfold.feature"){ 
    # This method centers each distribution in the median of the fold changes. 
    # Method following hpbenton idea. 
    average<-apply(originalIntensities, 1, median) # Changed to median and to hpbenton 
method (still original code) 
    # Replacing ceros for 0.0001 to avoid NaN or Inf values. 
    average[which(average==0)]<-0.0001 
    foldpersample<-sapply(1:dim(originalIntensities)[2], function(index){ 
      return(originalIntensities[,index]/average[index]) 
    }) 
    mfnormalizedIntensities<-t(sapply(1:dim(originalIntensities)[1], function(index){ 
      return(originalIntensities[index,]/median(foldpersample)) 
    })) 
    #    colnames(mfnormalizedIntensities)<-colnames(originalIntensities)   
#    mfnormalizedIntensities<-data.frame(mfnormalizedIntensities) 
#    output<-cbind(meta, mfnormalizedIntensities) 
#    output<-t(apply(output, 1, unlist)) 
    normalizedIntensities<-mfnormalizedIntensities 
    normalizedIntensities<-t(apply(normalizedIntensities, 1, unlist)) 
  } 
  else if(method=="medianfold.limma"){ 
    # This method centers each distribution in the median of the fold changes. 
    # Method using the normalizeMedianValues() function from the limma package. 
    mfnormalizedIntensities<-normalizeMedianValues(originalIntensities) 
    mfnormalizedIntensities<-data.frame(mfnormalizedIntensities) 
#    output<-cbind(meta, mfnormalizedIntensities) 
    normalizedIntensities<-mfnormalizedIntensities 
  } else 
    return(NULL) 
  if(columns1==min(blank.columns)){  # Blank samples are immediately after meta data. 
    output<-cbind(xsetTable[,1:max(blank.columns)], normalizedIntensities) 
  } else 
    output<-cbind(cbind(meta, normalizedIntensities), xsetTable[,blank.columns]) 
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# The following function removes all the rows (features) that contain a feature that was either 
UP  
# or DOWN expressed in the control comparison. 





removeFalsePositives<-function(tabla, controles, UPandDOWN=TRUE, fc.cutoff=1.5, 
pval.cutoff=0.05){ 
 # Separate fold change and pvalue 
 fc.control<-seq(controles[1], controles[length(controles)], 2) 
 pval.control<-seq(controles[1]+1, controles[length(controles)], 2) 
 # A fold change of 0 means that the Control in the pairwise comparison was 0 while 
in the sample 
 # was some value different than 0. While NaN means that the feature was not 
detected in any of  
 # the two samples compared. 
 if(UPandDOWN==TRUE){ 
  vector<-apply(tabla, 1, function(linea){ 
   flag<-TRUE # the row is not eliminated 
   # First, NaN? 
   if(is.na(linea[fc.control]) || is.na(linea[pval.control])) 
    return(flag) # No need to filter. 
   if(linea[fc.control]>=fc.cutoff || linea[fc.control]<=1/fc.cutoff) 
    if(linea[pval.control]<=pval.cutoff) 
     flag<-FALSE # FALSE means it was 
overexpressed and must be removed. 
   return(flag) 
  }) 
 } 
 if(UPandDOWN=="UP"){ 
 # This is in case it is specified that only features in the right column (Control) must 
be UP regulated 
 # in order to be removed from the table. 
  vector<-apply(tabla, 1, function(linea){ 
   flag<-TRUE # the row is not eliminated 
   # First, NaN? 
   if(is.na(linea[fc.control]) || is.na(linea[fc.control])) 
    return(flag) # No need to filter. 
   if(linea[fc.control]>=fc.cutoff) 
    if(linea[pval.control]<=pval.cutoff) 
     flag<-FALSE # FALSE means it was 
overexpressed and must be removed. 
   return(flag) 
  }) 
 } 
 if(UPandDOWN=="DOWN"){ 
 # This is in case it is specified that only features in the left column (Sample) must be 
UP regulated 
 # in order to be removed from the table. 
  vector<-apply(tabla, 1, function(linea){ 
   flag<-TRUE # the row is not eliminated 
   # First, NaN? 
   if(is.na(linea[fc.control]) || is.na(linea[fc.control])) 
    return(flag) # No need to filter. 
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   if(linea[fc.control]<=1/fc.cutoff) 
    if(linea[pval.control]<=pval.cutoff) 
     flag<-FALSE # FALSE means it was 
overexpressed and must be removed. 
   return(flag) 






# This function calculates the Fold change and P-value for each pairwise comparison. 
## USAGE: todos<-fcpvalue(todos, samples=c(11:12), controls=c(9:10), "Pf") 
fcpvalue<-function(tabla, samples, controls, name){ 
 temp<-t(apply(tabla, 1, function(linea){ 
  fc<-
median(as.numeric(linea[samples]))/median(as.numeric(linea[controls])) 
#  if(fc<1) 
#   fc<-(-1/fc) 
  obj<-try(t.test(x=linea[samples], y=linea[controls], var.equal=FALSE), 
silent=TRUE) 
  if (is(obj, "try-error"))  
   pvalue<-NA 
  else 
   pvalue<-obj$p.value 
#  pvalue<-t.test(x=linea[samples], y=linea[controls], 
var.equal=FALSE)$p.value 
  temp<-c(fc, pvalue) 
  names(temp)<-c(paste(name, "fc", sep="."), paste(name, "pval", sep=".")) 
  return(temp) 
 })) 




# The following function returns only the features that have a mzmed between the given range. 
## UPPlasmodium_mzfilter<-mzmedFilter(UPPlasmodium) 
mzmedFilter<-function(tabla, mzmed=1, minimum=500, maximum=1000){ 
# mzmed<-which(colnames(tabla)=="mzmed") 





# This function filters the features with a retention time (rt) outside the established minimum 
and 
# maximum values. 
rtFilter<-function(tabla, rt=4, minimum=3*60, maximum=14*60){ 









# to their corresponding control. 
## USAGE: UPPlasmodium<-UPorDOWNregulated(todosPlasmoyControls_Substracted, 
21:24, regulation="UP", fc.cutoff=1.5, pval.cutoff=0.05) 
UPorDOWNregulated<-function(tabla, samples, regulation="UP", fc.cutoff=1.5, 
pval.cutoff=0.05, biolRep.cutoff=0.66){ 
 fc.sample<-seq(samples[1], samples[length(samples)], 2) 
 pval.sample<-seq(samples[1]+1, samples[length(samples)], 2) 
 vector<-apply(tabla, 1, function(linea){ 
  flag<-TRUE # the row is not eliminated 
  # First, it is expressed in the sample? (different of NaN) 
  if(sum(!is.na(linea[fc.sample]))<biolRep.cutoff*length(fc.sample) || 
sum(!is.na(linea[pval.sample]))<biolRep.cutoff*length(pval.sample)) 
   # I need a certain proportion of the samples to be UP regulated, 
otherwise they are not markers for the samples. 
    flag<-FALSE # The feature is not present, must 
be filtered out (FALSE). 
  else if(regulation=="UP"){ 
  
 if(sum(linea[fc.sample]>=fc.cutoff)<biolRep.cutoff*length(fc.sample) || 
sum(linea[pval.sample]<=pval.cutoff)<biolRep.cutoff*length(pval.sample)) 
    flag<-FALSE # The feature is not present above 
the necessary fold change and under the pvalue thresholds, must be filtered out (FALSE). 
  } 
  else if(regulation=="DOWN"){ 
  
 if(sum(linea[fc.sample]<1/fc.cutoff)<biolRep.cutoff*length(fc.sample) || 
sum(linea[pval.sample]<=pval.cutoff)<biolRep.cutoff*length(pval.sample)) 
    flag<-FALSE # The feature is not present above 
the necessary fold change and under the pvalue thresholds, must be filtered out (FALSE). 
  } 






# The following function retrieves the closest possible isotope to given m/z and rt values, 
considering 
# a threshold for the m/z and the rt values. 'right' if TRUE indicates that the isotope (or adduct) 
will 
# be search in the M+1 range, is FALSE in the M-1 range. If intensityFilter is TRUE, the 
isotope (adduct) 
# must have a median intensity value smaller than the median intesity value of the given m/z. 
# When using right=FALSE, the returned ratio will be greater than 1, confirming that the 
isotope was found with a lower m/z value. 
# USAGE: Isotope(856.5959, 484.005, todos, intensCols=c(11:16)) 
#mz=856.5959; rt=484.005; tabla=todos; right=TRUE; mzthreashold=0.0150; 
rtthreashold=3.000; mzcolumn=1; rtcolumn=4; intensityFilter=TRUE; intensCols=c(11:16); 
half=FALSE 
Isotope<-function(mz, rt, tabla, right=TRUE, mzthreashold=0.0150, rtthreashold=3.000, 
mzcolumn=1, rtcolumn=4, intensityFilter=TRUE, intensCols=NULL, half=FALSE){ 
  tabla<-tabla[which(tabla[,rtcolumn]>=rt-rtthreashold & tabla[,rtcolumn]<=rt+rtthreashold),] 
# Selects rows with close rt value 
  if(dim(tabla)[1]<1) 
    return(print("This feature does not exist!!")) 
  # Once we know the feature with the given mz is in 'tabla' we calculate the median intensity 
for  
  # M (mz) before we replace it. 
  intM<-median(as.numeric(as.character(masCercano(mz, tabla, mzcolumn)[intensCols]))) 
  if(half==FALSE){ 
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    amount<-1 
  } else 
    amount<-0.5 
  if(right){  # Adds 'amount' to m/z value 
    right<-amount 
  } else 
    right<--amount 
  tabla<-tabla[which(tabla[,mzcolumn]>=mz+right-mzthreashold & 
tabla[,mzcolumn]<=mz+right+mzthreashold),] # Selects rows with close m/z value 
  if(is.null(dim(tabla))) 
    return(print("No features where found!!")) 
  if(dim(tabla)[1]<1) 
      return(print("No features where found!!")) 
  if(intensityFilter){  # The isotope (adduct) must have a median intensity value smaller than 
the median intesity value of the given m/z. 
    vectorints<-rep(NA, dim(tabla)[1]) 
    for(i in 1:dim(tabla)[1]){  # In case more than one row exists in 'tabla' the opportunity is 
given to check if one of them has an expected intensity. 
      intM1<-median(as.numeric(as.character(tabla[i, intensCols]))) 
      vectorints[i]<-intM1/intM 
    } 
    if(right>0){ 
      lower.values<-vectorints<1  # TRUE means this rows had an median intensity lower than 
the intensity of the given m/z value 
    } else 
      lower.values<-vectorints>1 
    candidate<-which(abs(tabla[which(lower.values),mzcolumn]-
(mz+right))==min(abs(tabla[which(lower.values),mzcolumn]-(mz+right)))) 
    # candidate contains the number of the row with the closest m/z value to the expected 
isotope (adduct). 
    print(paste(" Intensities ratio of the new m/z value (", tabla[candidate, mzcolumn], ") over 
the original feature (", mz, ") is: ", vectorints[candidate], sep="")) 
  } 
  else {  # The closes mz value to the M+-right will be taken 
    candidate<-which(abs(tabla[,mzcolumn]-(mz+right))==min(abs(tabla[,mzcolumn]-
(mz+right)))) 
  } 
  tabla<-tabla[candidate,] 
  if(dim(tabla)[1]<1) 
    return(print("No features with lower intensity where found!!")) 




# The following function returns a table with the features that correspond to M and not to M+1 
values. 
# Given that a standard Lipid feature has isotopes/adducts with M+1 and sometimes M+2, 
features without this signals are also filtered when subfeatures=TRUE 
# USAGE: isotopeFilter(UPPv, evalue=21, todos, intensCols=c(11:16)) 
# tabla.UPDOWN=UPPv; evalue=21; tabla.originals=todos; intensCols=c(11:16); 
right=TRUE; mzthreashold=0.0150; rtthreashold=3.000; mzcolumn=1; rtcolumn=4; 
intensityFilter=TRUE; subfeatures=TRUE; half=FALSE 
isotopeFilter<-function(tabla.UPDOWN, evalue=21, tabla.originals, subfeatures=TRUE, 
intensCols=NULL, right=TRUE, mzthreashold=0.0150, rtthreashold=3.000, mzcolumn=1, 
rtcolumn=4, intensityFilter=TRUE, half=FALSE){ 
  # The following conversion will ensure that the variable 'tabla' will always have dimension 
even 
  # in the case where only one line is taken. 
  tabla.originals<-as.data.frame(tabla.originals) 
  # Ordering tabla.UPDOWN based on evalue 
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  tabla.UPDOWN<-tabla.UPDOWN[order(tabla.UPDOWN[ ,evalue]), ] 
  candidatos<-t(apply(tabla.UPDOWN, 1, function(linea){ 
    #    linea<-tabla.UPDOWN[1,] 
    linea<-as.numeric(linea) 
    toreturn<-rep(NA, 6) 
    elisotopo<-Isotope(linea[mzcolumn], linea[rtcolumn], tabla.originals, 
intensCols=intensCols, right=FALSE, mzthreashold=mzthreashold, rtthreashold=rtthreashold, 
mzcolumn=mzcolumn, rtcolumn=rtcolumn, intensityFilter=intensityFilter, half=half) 
    # If searching to the left retrieves a result then this feature will not taken into account. 
    if(!is.character(elisotopo))  # In case a data.frame is retrieved, then this feature should not be 
considered. 
      return(toreturn) 
    if(!subfeatures){ 
      toreturn[1]<-linea[mzcolumn] 
      toreturn[2]<-median(as.numeric(as.character(masCercano(linea[mzcolumn], 
tabla.originals, mzcolumn)[1,intensCols]))) 
      elisotopo<-as.numeric(Isotope(linea[mzcolumn], linea[rtcolumn], tabla.originals, 
intensCols=intensCols, right=TRUE, mzthreashold=mzthreashold, rtthreashold=rtthreashold, 
mzcolumn=mzcolumn, rtcolumn=rtcolumn, intensityFilter=intensityFilter, half=half)) 
      if(!is.character(elisotopo)){ 
        toreturn[3]<-elisotopo[mzcolumn] 
        toreturn[4]<-median(elisotopo[intensCols]) 
        elisotopo<-as.numeric(Isotope(elisotopo[mzcolumn], elisotopo[rtcolumn], tabla.originals, 
intensCols=intensCols, right=TRUE, mzthreashold=mzthreashold, rtthreashold=rtthreashold, 
mzcolumn=mzcolumn, rtcolumn=rtcolumn, intensityFilter=intensityFilter, half=half)) 
        if(length(elisotopo)>1){ 
          toreturn[5]<-elisotopo[mzcolumn] 
          toreturn[6]<-median(elisotopo[intensCols]) 
        } 
      } 
    } else {  # subfeatures==TRUE, then it is requiered to have at least the M+1 feature 
      elisotopo<-as.numeric(Isotope(linea[mzcolumn], linea[rtcolumn], tabla.originals, 
intensCols=intensCols, right=TRUE, mzthreashold=mzthreashold, rtthreashold=rtthreashold, 
mzcolumn=mzcolumn, rtcolumn=rtcolumn, intensityFilter=intensityFilter, half=half)) 
      if(length(elisotopo)>1){ 
        toreturn[1]<-linea[mzcolumn] 
        toreturn[2]<-median(as.numeric(as.character(masCercano(linea[mzcolumn], 
tabla.originals, mzcolumn)[1,intensCols]))) 
        toreturn[3]<-elisotopo[mzcolumn] 
        toreturn[4]<-median(elisotopo[intensCols]) 
        elisotopo<-as.numeric(Isotope(elisotopo[mzcolumn], elisotopo[rtcolumn], tabla.originals, 
intensCols=intensCols, right=TRUE, mzthreashold=mzthreashold, rtthreashold=rtthreashold, 
mzcolumn=mzcolumn, rtcolumn=rtcolumn, intensityFilter=intensityFilter, half=half)) 
        if(length(elisotopo)>1){ 
          toreturn[5]<-elisotopo[mzcolumn] 
          toreturn[6]<-median(elisotopo[intensCols]) 
        } 
      } 
    } 
    # Returning: c(M_mz, M_medintensity, M1_mz, M1_medintensity, M2_mz, 
M2_medintensity) 
    return(toreturn) 
  }))   
  colnames(candidatos)<-c("M.mz", "M.int", "M1.mz", "M1.int", "M2.mz", "M2.int") 











ObtainingCandidates<-function(data.dir, results.dir, normalization.method=FALSE, 
blank.columns=NULL){ 
  setwd(results.dir) 
  sink("Results.txt") 
  print(Sys.time()) 
  library(xcms) 
  library(limma) 
  rawDataFiles <- list.files(data.dir, recursive = TRUE, full.names = TRUE) 
  # Feature detection: 
  xset <- xcmsSet(rawDataFiles, nSlaves=4, method="centWave", ppm=30, 
peakwidth=c(15,30), snthresh=10, 
                  prefilter=c(2,1000), integrate=1, mzdiff=0.01, fitgauss=FALSE, 
polarity="negative") 
  # Retention time correction 
  xset1<-retcor(xset, method="obiwarp", plottype=c("deviation"), profStep=1) 
  # Alignment 
  xset2<-group(xset1, bw=5,mzwid=0.015,minfrac=0.5) 
  xset3<-fillPeaks(xset2) 
  todos<-peakTable(xset3) 
  print(" Printing table 'todos.tsv'") 
  write.table(todos, "todos.tsv", quote=FALSE) 
  if(normalization.method!=FALSE){ 
    todos.normalized<-featureNormalization(xset3, method=normalization.method, 
blank.columns=c(9:10)) 
  } 
  else 
    todos.normalized<-todos 
  print(" Printing table 'todos_normalized.tsv'") 
  write.table(todos.normalized, "todos_normalized.tsv", quote=FALSE) 
   
  errores<-c(errorPerc(todos, 9,10), errorPerc(todos, 11,12), errorPerc(todos, 13,14), 
errorPerc(todos, 15,16), 
             errorPerc(todos, 17,18), errorPerc(todos, 17,19), errorPerc(todos, 18,19)) 
 
  print(summary(errores)) 
  names(errores)<-c("Blank", "Pv1", "PV3", "PV5", "Retics1", "Retics2", "Retics3") 
  print(errores) 
  postscript("Reproducibility_feature_detection.eps", horizontal=FALSE, onefile=FALSE, 
paper="special", width=10, height=8) 
  barplot(errores, col=colorRampPalette(c("deepskyblue2", "limegreen"))(7), 
main="Reproducibility in feature detection", 
          xlab=NA, ylab="Reproducibility", las=2, ylim=c(0,100)) 
  dev.off() 
   
  print(" Dimension of 'todos' table:") 
  print(dim(todos)) 
   
  todosPv<-filterTechReps(todos, 11:12) 
  todosPv<-filterTechReps(todosPv, 13:14) 
  todosPv<-filterTechReps(todosPv, 15:16) 
  print(" Dimension of the table after filtering technical replicates in 'Sample': ") 
  print(dim(todosPv)) 
  todosPvRetics<-filterTechReps(todosPv, 17:19) 
  print(" Dimension of the table after filtering technical replicates in 'Control': ") 
  print(dim(todosPvRetics)) 
  todosPvReticsBlank<-filterTechReps(todosPvRetics, 9:10) 
  print(" Dimension of the table after filtering technical replicates in 'Blank': ") 
  print(dim(todosPvReticsBlank)) 
  blankTable<-fcpvalue(todosPvReticsBlank, samples=c(9:10), controls=c(11:19), "Blank") 
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  blankTable_Substracted<-removeFalsePositives(blankTable, 20:21, UPandDOWN="UP") 
  print("Dimension of the table after removing False Positive features: ") 
  print(dim(blankTable_Substracted)) 
   
  # Lines from 'todos.normalized' are taken if they were not filtered out by 
removeFalsePositives() 
  normalizedTable<-todos.normalized[which(rownames(todos.normalized) %in% 
rownames(blankTable_Substracted)), ] 
  normalizedTable<-fcpvalue(normalizedTable, samples=c(11:16), controls=c(17:19), "Pv") 
  print(" Printing table 'normalizedTable_Subtracted.tsv'") 
  write.table(normalizedTable, quote=FALSE, "normalizedTable_Subtracted.tsv") 
  normalizedTable<-mzmedFilter(normalizedTable, minimum=300, 
maximum=max(normalizedTable[,1])) 
  print(" Dimension of the table after filtering for m/z value: ") 
  print(dim(normalizedTable)) 
  normalizedTable<-rtFilter(normalizedTable) 
  print(" Dimension of the table after filtering for retention time value: ") 
  print(dim(normalizedTable)) 
 
  UPPv<-UPorDOWNregulated(normalizedTable, 20:21, regulation="UP", fc.cutoff=1.5, 
pval.cutoff=0.05) 
  UPRetic<-UPorDOWNregulated(normalizedTable, 20:21, regulation="DOWN", 
fc.cutoff=1.5, pval.cutoff=0.05) 
  print(" Dimension of the table containing UP regulated features in Pv: ") 
  print(dim(UPPv)) 
  print(" Dimension of the table containing UP regulated features in Reticulocytes: ") 
  print(dim(UPRetic)) 
   
  print(" Filtering mono-Isotopes in UPPv ") 
  candidatos<-isotopeFilter(UPPv, evalue=21, todos, intensCols=c(11:16)) 
  tabla.UPDOWN<-UPPv[order(UPPv[ ,21]), ] 
  tabla.UPPv<-tabla.UPDOWN[which(!is.na(candidatos[,1])), ] 
  print(" Dimension of the table containing UP regulated  Mono-isotopes in Pv: ") 
  print(dim(tabla.UPPv)) 
  print(" Printing table 'tabla.UPPv.tsv'") 
  write.table(tabla.UPPv, quote=FALSE, "tabla.UPPv.tsv") 
 
  print(" Plotting isotopic distributions in UPPv (Candidates)") 
  candidatos.filtered<-candidatos[which(!is.na(candidatos[,1])), ] 
  postscript("IsotopicDistributions_UPPv_Candidates.eps", horizontal=FALSE, 
onefile=FALSE, paper="special", width=10, height=8) 
  par(mfrow=c(3,5)) 
  for(i in 1:min(15, dim(tabla.UPPv)[1])){ 
    plot(NA, xlim=c(min(candidatos.filtered[i,c(1,3,5)], na.rm=TRUE)-1.5, 
max(candidatos.filtered[i,c(1,3,5)], na.rm=TRUE)+1.5), ylim=c(0, 
max(candidatos.filtered[i,c(2,4,6)], na.rm=TRUE)), 
         xlab="m/z", ylab="Intensity", main=paste("Isotopic distribution 
Retention time: ", masCercano(candidatos.filtered[i,1], UPPv, 1)[4], sep="")) 
    lines(candidatos.filtered[i, c(1,3,5)], candidatos.filtered[i, c(2,4,6)], type="h", col=c("red", 
"black", "black")) 
  } 
  dev.off() 
 
  print(" Plotting isotopic distributions in UPPv (Eliminated)") 
  eliminatedcandidates.index<-which(is.na(candidatos[,1])) 
  ordenados<-UPPv[order(UPPv[,21]),] 
  eliminatedcandidates.row<-ordenados[eliminatedcandidates.index,] 
   
  tabla.UPDOWN=eliminatedcandidates.row; evalue=21; tabla.originals=todos; 
intensCols=c(11:16); right=TRUE; mzthreashold=0.0150; rtthreashold=2.500; mzcolumn=1; 
rtcolumn=4; intensityFilter=FALSE; subfeatures=FALSE; 
  candidatos.elim<-t(apply(eliminatedcandidates.row, 1, function(linea){ 
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    #    linea<-eliminatedcandidates.row[1,] 
    linea<-as.numeric(linea) 
    toreturn<-rep(NA, 8)  # space for a feature on the left. 
    elisotopo<-as.numeric(Isotope(linea[mzcolumn], linea[rtcolumn], tabla.originals, 
intensCols=intensCols, right=FALSE, intensityFilter=FALSE)) 
    toreturn[1]<-elisotopo[mzcolumn] 
    toreturn[2]<-median(elisotopo[intensCols]) 
    toreturn[3]<-linea[mzcolumn] 
    toreturn[4]<-median(as.numeric(as.character(masCercano(linea[mzcolumn], tabla.originals, 
mzcolumn)[1,intensCols]))) 
    elisotopo<-as.numeric(Isotope(linea[mzcolumn], linea[rtcolumn], tabla.originals, 
intensCols=intensCols, right=TRUE, intensityFilter=FALSE)) 
    toreturn[5]<-elisotopo[mzcolumn] 
    toreturn[6]<-median(elisotopo[intensCols]) 
    elisotopo<-as.numeric(Isotope(elisotopo[mzcolumn], elisotopo[rtcolumn], tabla.originals, 
intensCols=intensCols, right=TRUE, intensityFilter=FALSE)) 
    toreturn[7]<-elisotopo[mzcolumn] 
    toreturn[8]<-median(elisotopo[intensCols]) 
    # Returning: c(M_mz, M_medintensity, M1_mz, M1_medintensity, M2_mz, 
M2_medintensity) 
    return(toreturn) 
  })) 
  colnames(candidatos.elim)<-c("M_1.mz", "M_1.int", "M.mz", "M.int", "M1.mz", "M1.int", 
"M2.mz", "M2.int") 
  postscript("IsotopicDistributions_UPPv_Eliminated1.eps", horizontal=FALSE, 
onefile=FALSE, paper="special", width=10, height=8) 
  par(mfrow=c(3,5)) 
  for(i in 1:min(15, dim(candidatos.elim)[1])){ 
    plot(NA, xlim=c(min(candidatos.elim[i,c(1,3,5,7)], na.rm=TRUE)-1.5, 
max(candidatos.elim[i,c(1,3,5,7)], na.rm=TRUE)+1.5), ylim=c(0, 
max(candidatos.elim[i,c(2,4,6,8)], na.rm=TRUE)), 
         xlab="m/z", ylab="Intensity", main=paste("Isotopic distribution 
Retention time: ", masCercano(candidatos.elim[i,3], UPPv, 1)[4], sep="")) 
    lines(candidatos.elim[i, c(1,3,5,7)], candidatos.elim[i, c(2,4,6,8)], type="h", col=c("black", 
"red", "black", "black")) 
  } 
  dev.off() 
   
  print(" Filtering mono-Isotopes in UPRetic ") 
  candidatos<-isotopeFilter(UPRetic, evalue=21, todos, intensCols=c(17:19)) 
  tabla.UPDOWN<-UPRetic[order(UPRetic[ ,21]), ] 
  tabla.UPRetic<-tabla.UPDOWN[which(!is.na(candidatos[,1])), ] 
  print(" Dimension of the table containing UP regulated  Mono-isotopes in Reticulocytes: ") 
  print(dim(tabla.UPRetic)) 
  print(" Printing table 'tabla.UPRetic.tsv'") 
  write.table(tabla.UPRetic, quote=FALSE, "tabla.UPRetic.tsv") 
   
  print(" Plotting isotopic distributions in UPRetic (Candidates)") 
  candidatos.filtered<-candidatos[which(!is.na(candidatos[,1])), ] 
  postscript("IsotopicDistributions_UPRetic_Candidates.eps", horizontal=FALSE, 
onefile=FALSE, paper="special", width=10, height=8) 
  par(mfrow=c(3,5)) 
  for(i in 1:min(15, dim(tabla.UPRetic)[1])){ 
    plot(NA, xlim=c(min(candidatos.filtered[i,c(1,3,5)], na.rm=TRUE)-1.5, 
max(candidatos.filtered[i,c(1,3,5)], na.rm=TRUE)+1.5), ylim=c(0, 
max(candidatos.filtered[i,c(2,4,6)], na.rm=TRUE)), 
         xlab="m/z", ylab="Intensity", main=paste("Isotopic distribution 
Retention time: ", masCercano(candidatos.filtered[i,1], UPRetic, 1)[4], sep="")) 
    lines(candidatos.filtered[i, c(1,3,5)], candidatos.filtered[i, c(2,4,6)], type="h", col=c("red", 
"black", "black")) 
  } 
  dev.off() 
85 
 
   
  print(" Identifying which features inside 'tabla.UPPv' that have 'half-features' only at the 
right") 
  candidatos.half<-isotopeFilter(tabla.UPPv, evalue=21, todos, intensCols=c(11:16), 
half=TRUE) 
  print(" Printing the candidates with a feature in the M+0.5 range: ") 
  print(candidatos.half[!is.na(candidatos.half[,1]),]) 
  print(" Identifying which features inside 'tabla.UPPv' that have 'half-features' at the left") 
  eliminatedcandidates.index<-which(is.na(candidatos.half[,1])) 
  ordenados<-tabla.UPPv[order(tabla.UPPv[,21]),] 
  eliminatedcandidates.row<-ordenados[eliminatedcandidates.index,] 
   
  tabla.UPDOWN=eliminatedcandidates.row; evalue=21; tabla.originals=todos; 
intensCols=c(11:16); right=TRUE; mzthreashold=0.0150; rtthreashold=2.500; mzcolumn=1; 
rtcolumn=4; intensityFilter=FALSE; subfeatures=FALSE; half=TRUE 
  candidatos.elim<-t(apply(eliminatedcandidates.row, 1, function(linea){ 
    #    linea<-eliminatedcandidates.row[1,] 
    linea<-as.numeric(linea) 
    toreturn<-rep(NA, 8)  # space for a feature on the left. 
    elisotopo<-as.numeric(Isotope(linea[mzcolumn], linea[rtcolumn], tabla.originals, 
intensCols=intensCols, right=FALSE, intensityFilter=FALSE, half=half)) 
    toreturn[1]<-elisotopo[mzcolumn] 
    toreturn[2]<-median(elisotopo[intensCols]) 
    toreturn[3]<-linea[mzcolumn] 
    toreturn[4]<-median(as.numeric(as.character(masCercano(linea[mzcolumn], tabla.originals, 
mzcolumn)[1,intensCols]))) 
    elisotopo<-as.numeric(Isotope(linea[mzcolumn], linea[rtcolumn], tabla.originals, 
intensCols=intensCols, right=TRUE, intensityFilter=FALSE, half=half)) 
    toreturn[5]<-elisotopo[mzcolumn] 
    toreturn[6]<-median(elisotopo[intensCols]) 
    elisotopo<-as.numeric(Isotope(elisotopo[mzcolumn], elisotopo[rtcolumn], tabla.originals, 
intensCols=intensCols, right=TRUE, intensityFilter=FALSE, half=half)) 
    toreturn[7]<-elisotopo[mzcolumn] 
    toreturn[8]<-median(elisotopo[intensCols]) 
    # Returning: c(M_mz, M_medintensity, M1_mz, M1_medintensity, M2_mz, 
M2_medintensity) 
    return(toreturn) 
  })) 
  colnames(candidatos.elim)<-c("M_1.mz", "M_1.int", "M.mz", "M.int", "M1.mz", "M1.int", 
"M2.mz", "M2.int") 
  print(" Printing the candidates with a feature in the M-0.5 range: ") 
  print(candidatos.elim[!is.na(candidatos.elim[,1]),]) 
   
  print(" Identifying which features inside 'tabla.UPRetic' that have 'half-features' only at the 
right") 
  candidatos.half<-isotopeFilter(tabla.UPRetic, evalue=21, todos, intensCols=c(11:16), 
half=TRUE) 
  print(" Printing the candidates with a feature in the M+0.5 range: ") 
  print(candidatos.half[!is.na(candidatos.half[,1]),]) 
  print(" Identifying which features inside 'tabla.UPRetic' that have 'half-features' at the left") 
  eliminatedcandidates.index<-which(is.na(candidatos.half[,1])) 
  ordenados<-tabla.UPRetic[order(tabla.UPRetic[,21]),] 
  eliminatedcandidates.row<-ordenados[eliminatedcandidates.index,] 
   
  tabla.UPDOWN=eliminatedcandidates.row; evalue=21; tabla.originals=todos; 
intensCols=c(11:16); right=TRUE; mzthreashold=0.0150; rtthreashold=2.500; mzcolumn=1; 
rtcolumn=4; intensityFilter=FALSE; subfeatures=FALSE; half=TRUE 
  candidatos.elim<-t(apply(eliminatedcandidates.row, 1, function(linea){ 
    #    linea<-eliminatedcandidates.row[1,] 
    linea<-as.numeric(linea) 
    toreturn<-rep(NA, 8)  # space for a feature on the left. 
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    elisotopo<-as.numeric(Isotope(linea[mzcolumn], linea[rtcolumn], tabla.originals, 
intensCols=intensCols, right=FALSE, intensityFilter=FALSE, half=half)) 
    toreturn[1]<-elisotopo[mzcolumn] 
    toreturn[2]<-median(elisotopo[intensCols]) 
    toreturn[3]<-linea[mzcolumn] 
    toreturn[4]<-median(as.numeric(as.character(masCercano(linea[mzcolumn], tabla.originals, 
mzcolumn)[1,intensCols]))) 
    elisotopo<-as.numeric(Isotope(linea[mzcolumn], linea[rtcolumn], tabla.originals, 
intensCols=intensCols, right=TRUE, intensityFilter=FALSE, half=half)) 
    toreturn[5]<-elisotopo[mzcolumn] 
    toreturn[6]<-median(elisotopo[intensCols]) 
    elisotopo<-as.numeric(Isotope(elisotopo[mzcolumn], elisotopo[rtcolumn], tabla.originals, 
intensCols=intensCols, right=TRUE, intensityFilter=FALSE, half=half)) 
    toreturn[7]<-elisotopo[mzcolumn] 
    toreturn[8]<-median(elisotopo[intensCols]) 
    # Returning: c(M_mz, M_medintensity, M1_mz, M1_medintensity, M2_mz, 
M2_medintensity) 
    return(toreturn) 
  })) 
  colnames(candidatos.elim)<-c("M_1.mz", "M_1.int", "M.mz", "M.int", "M1.mz", "M1.int", 
"M2.mz", "M2.int") 
  print(" Printing the candidates with a feature in the M-0.5 range: ") 
  print(candidatos.elim[!is.na(candidatos.elim[,1]),]) 
   
   
  print(" DONE!! ") 
  print(Sys.time()) 




# Function to extract the spectra corresponding to a given m/z and rt, given respective 
thresholds. 
# The retention time is always considered in seconds. 
## USAGE: 
extractingSpectra(mgf.file="MSMS/mspepsearchC8/C8_PV_targetedMSMSpos_6and4_3collr
1.mgf", candidates.file="Candidates_PositiveMode.UPPv_wSample.tsv", mz.col=1, rt.col=2, 
output.file="MSMS/mspepsearchC8/December/C8_PV_targetedMSMSpos_Filtered.mgf") 
extractingSpectra<-function(mgf.file, candidates.file, mz.col=1, rt.col=2, output.file, 
mz.threshold=0.015, rt.threshold=30){ 
  # mgf.file="MSMS/mspepsearchC8/C8_PV_targetedMSMSpos_6and4_3collr1.mgf"; 
candidates.file="Candidates_PositiveMode.UPPv_wSample.tsv"; mz.col=1; rt.col=2; 
output.file="MSMS/mspepsearchC8/December/C8_PV_targetedMSMSpos_Filtered.mgf"; 
mz.threshold=0.015; rt.threshold=30 
  # Reading files: 
  mgf.file<-readLines(mgf.file) 
  candidates.file<-read.table(candidates.file, header=TRUE) 
  # Indexing the mgf file: 
  PEPMASS.lines<-grep("PEPMASS=", mgf.file) 
  RTINSECONDS.lines<-grep("RTINSECONDS=", mgf.file) 
  PEPMASS.values<-as.numeric(sub("PEPMASS=(.+) ", "\\1", mgf.file[PEPMASS.lines], 
perl=TRUE)) 
  RTINSECONDS.values<-as.numeric(sub("RTINSECONDS=(.+)", "\\1", 
mgf.file[RTINSECONDS.lines], perl=TRUE)) 
  # Finding MS/MS spectra for the given candidates: 
  subset<-NULL 
  for(i in 1:dim(candidates.file)[1]){ 
    goodmz<-which(abs(PEPMASS.values-candidates.file[i,mz.col])<=mz.threshold) 




    goodmzrt.rtlines<-RTINSECONDS.lines[goodmz][goodmzrt] 
    for(j in 1:length(goodmzrt.rtlines)){ 
      begin.ions<-goodmzrt.rtlines[j]-4 
      for (end.ions in (goodmzrt.rtlines[j]+2):length(mgf.file)) 
        if(mgf.file[end.ions]=="END IONS") 
          break 
      subset<-c(subset, mgf.file[begin.ions:end.ions]) 
      #writeLines(subset, out.mgf) 
    } 
  } 
  titulos<-grep("TITLE=", subset) 
  if(length(table(table(titulos)))>1) 
    print(" WARNING! At least one spectra is repeated due to overlaping in the Candidates file 
or by an unknown reason.") 




# Function to extract the Retention Time in seconds from the Unknown column 
## USAGE: Res.Pv.pos.lb<-getRTmins(Res.Pv.pos.lb) 
getRTmins<-function(tsv){ 
  #  tsv<-Res.Pv.pos.lb 
  rtstring<-sapply(tsv$Unknown, function(unknown){ 
    rtstring<-strsplit(as.character(unknown), " at ")[[1]][2] 
    rtstring<-as.numeric(strsplit(rtstring, " mins ")[[1]][1]) 
    return(rtstring) 
  }) 
  rtstring<-data.frame(rt.min=rtstring) 
  tsv<-cbind(tsv, rtstring) 




# Function to concatenate two .tsv files using the same query .mgf but different databases in 
MSPepSearch 
## USAGE: Res.Pv.pos<-concatenate.tsvs(Res.Pv.pos.lb, Res.Pv.pos.custom) 
concatenate.tsvs<-function(tsv1, tsv2){ 
#  tsv1<-Res.Pv.pos.lb; tsv2<-Res.Pv.pos.custom 
  tsv<-rbind(tsv1, tsv2) 
  tsv<-tsv[order(tsv$rt.min),] 
#  tsv<-temp2 
  unique.queries<-unique(tsv$Num) 
  tsv.ordenado<-tsv[0,] 
  for(i in unique.queries){ 
    subset<-tsv[which(tsv$Num==i),] 
    tsv.ordenado<-rbind(tsv.ordenado, subset[order(-subset$Rev.Dot),]) 
  } 




# Function to identify the safest information from each precursor. 
# The degree of confidence can be: 
# 1. Lipid class (MGDG, PA, PC, DG, PC, PE, PS, CE, Plasmenyl-PC, and probably others). 
# 2. Subclass (GPser, GPCho, GPA, GPEtn, Cholesteryl ester). 
# 3. Total carbons in the fatty acyls and number of double bonds (PC 36:5, MGDG 30:3, 
plasmenyl-PC 36:4, 
#     PA 41:0, PE 37:4, CE(16:2), PS 41:3). 
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# 4. Distribution of the carbons and double bonds in the fatty acyls (GPEtn(17:2/20:2), PC(P-
20:0/20:4), 
#     GPCho(20:4/20:4), MGDG(15:0/17:1), DG(12:0/20:0/0:0), GPA(17:0/24:0), 
GPSer(15:1/26:2), PE(P-20:0/15:0)). 




  tsv<-tsv[which(tsv$Rev.Dot>=300),] 
  unique.queries<-unique(tsv$Num) 
#  Assigned<-data.frame(Num=NA, Precursor.m.z=NA, Library=NA, Rev.Dot=NA, LC=NA, 
Adduct=NA, sns=NA, sn1=NA, sn2=NA, sn3=NA, RTsec=NA) 
  Assigned<-rep(NA, 11) 
  for(i in unique.queries){ 
    subset<-tsv[which(tsv$Num==i),] 
    # If only one of the hits in 'subset' has a 'Rev.Dot' value higher or equal to 600, the 
assignment 
    # given to this hit is copied. 
    if(length(sub.subset<-which(subset$Rev.Dot>=600))==1){ 
      linea<-subset[sub.subset,c(1,3,5,13,14,22)] 
      lipid<-splitPeptide(linea[1,5]) 
      Assigned<-rbind(Assigned, cbind(linea[1,c(1:4,6)], t(lipid))) 
    } 
    # If more than one of the hits in 'subset' has a 'Rev.Dot' value higher or equal to 600, the 
shared 
    # assignment is copied. 
    else if(length(sub.subset) > 1){ 
      linea<-subset[which.max(subset$Rev.Dot[sub.subset]),c(1,3,5,13,14,22)] 
      df<-t(apply(subset, 1, function(linea){ 
        splitPeptide(linea[14]) 
      })) 
      lipid<-rep(NA, 7) 
      lipid[2]<-df[which.max(subset$Rev.Dot[sub.subset]),2] 
      if(length(unique(df[,1]))==1){ 
        lipid[1]<-df[1,1] 
        # The 'subclass' is checked before the number of carbons in the fatty acyls 
        if(length(unique(df[,4]))==1){ 
          lipid[4]<-df[1,4] 
          if(length(unique(df[,3]))==1){ 
            lipid[3]<-df[1,3] 
            if(length(unique(df[,5]))==1){ 
              lipid[5]<-df[1,5] 
              if(length(unique(df[,6]))==1){ 
                lipid[6]<-df[1,6] 
                if(length(unique(df[,7]))==1){ 
                  lipid[7]<-df[1,7] 
                } 
              } 
            } 
          } 
        } 
      } 
      Assigned<-rbind(Assigned, cbind(linea[1,c(1:4,6)], t(lipid))) 
    } 
    # If none of the hits in 'subset' has a 'Rev.Dot' value higher or equal to 600, nothing is 
copied. 
    else { 
      linea<-subset[which.max(subset$Rev.Dot),c(1,3,5,13,22)] 
      Assigned<-rbind(Assigned, cbind(linea, t(rep(NA, 7)))) 
    } 
  } 
  Assigned<-Assigned[2:dim(Assigned)[1],]     
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  colnames(Assigned)<-c(colnames(Assigned)[1:5], "LC", "Adduct", "sns", "subclass", "sn1", 
"sn2", "sn3") 




# Function to make clusters of mass spectra given a table coming from 
LipidClassAssignment() and a mz 
# threshold value. 
## USAGE: Ident.Retic.clustered<-clusteringSpectra(tabla=Ident.Retic, mz.threshold=0.02) 
clusteringSpectra<-function(tabla, mz.threshold=0.015){ 
#  tabla=Ident.Retic; mz.threshold=0.02; 
  tabla<-tabla[order(tabla$Precursor.m.z),] 
  tabla$diff.adducts<-rep(1, dim(tabla)[1]) 
  for(i in 1:(dim(tabla)[1]-1)){ 
#   i<-2 
    # Creating a subtable that contains precursors very close to the row 'i' 
    tabla.remaining<-tabla[(i+1):dim(tabla)[1],] 
    to.check<-which((tabla.remaining$Precursor.m.z-tabla[i,2])<=mz.threshold)+i 
    if(length(to.check)>0){ 
      for(j in to.check){ 
# j<-to.check[1] 
        # Verifying if this row belongs to a previous identified cluster 
        if(tabla$diff.adducts[j]>0){ 
          # Coming from a different adduct? If it comes from the same adduct it is not important, 
they will 
          # only have slightly different retention times (probably) 
          if(tabla[i,7]!=tabla[j,7]){ 
            # Having the same lipid assignation? 
            if(setequal(tabla[i,c(8:12)], tabla[j, c(8:12)])){ 
              tabla$diff.adducts[i]<-tabla$diff.adducts[i]+1 
            } 
          } else { 
            # Hits with the same adduct, but with different assignation? (coming from different RT) 
            if(setequal(tabla[i,c(8:12)], tabla[j, c(8:12)])){ 
              tabla$diff.adducts[j]<-0 
            } 
          } 
        } 
      } 
    } 
  } 




# Function to split the string of the 'Peptide' name into the vector of 6 values 
## USAGE: splited<-splitPeptide(elString) 
splitPeptide<-function(elString){ 
#  elString<-subset[1,14] 
  elString<-as.character(elString) 
  temp<-strsplit(elString, " ")[[1]]   
  Peptide.LC<-temp[1] 
  Peptide.Adduct<-strsplit(temp[3], ";")[[1]][1] 
  Peptide.sns<-strsplit(temp[2], ";")[[1]][1] 
  Peptide.subclass<-sub("(\\w+)\\(.+", "\\1", temp[4], perl=TRUE) 
  temp<-sub("(.+)\\(.+\\)(.+)", "\\1\\2", temp[4]) 
  temp<-sub("(.+)\\(.+\\)(.+)", "\\1\\2", temp) 
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  temp<-sub("(.+)\\(.+\\)(.+)", "\\1\\2", temp) 
  temp<-sub(".+\\((.+)\\)", "\\1", temp) 
  temp<-strsplit(temp, "/")[[1]] 
  Peptide.sn1<-temp[1] 
  Peptide.sn2<-temp[2] 
  if(Peptide.LC=="TG" || Peptide.LC=="DG" || Peptide.LC=="MG"){ 
    Peptide.sn3<-temp[3] 
  } else 








# Function to generate a mgf file with the spectra from a given mz/rt values 
## USAGE: getMGF(mz="836.5566406", rt="6.92803333333333", 
in.mgf="C8_PV_targetedMSMSneg_6and4_3collr1.mgf", out.mgf="salida.mgf") 
getMGF<-function(mz, rt, in.mgf, out.mgf="archivo_salida.mgf"){ 
#  mz=836.5566406; rt="6.92803333333333"; 
in.mgf="Retic_targetedMSMSpos_6and4_3coll.mgf"; out.mgf<-"archivo_salida.mgf" 
  in.mgf<-readLines(in.mgf) 
  elString<-paste("MS/MS of ", mz, " 1+ at ", rt, sep="") 
  TITLE<-grep(elString, in.mgf, fixed=TRUE) 
  if(length(TITLE)>1) 
    print(" WARNING: Something weird happened!!") 
  begin.ions<-TITLE-3 
  for (end.ions in (TITLE+3):length(in.mgf)) 
    if(in.mgf[end.ions]=="END IONS") 
      break 
  subset<-in.mgf[begin.ions:end.ions] 




# Function to generate a mgf file with the spectra from a given mz/rt approximate values 
## USAGE: getMGF.feelinglucky(mz="836.5566406", rt="6.92803333333333", 
in.mgf="Retic_targetedMSMSpos_6and4_3coll.mgf", out.mgf="salida.mgf") 
getMGF.feelinglucky<-function(mz, rt, in.mgf, out.mgf="archivo_salida.mgf"){ 
  #  mz=836.5566; rt=6.92803; in.mgf="Retic_targetedMSMSpos_6and4_3coll.mgf"; 
out.mgf<-"archivo_salida.mgf" 
  in.mgf<-readLines(in.mgf) 
  TITLE<-grep(paste(".+MS/MS of ", mz, ".+ 1\\+ at ", rt, sep=""), in.mgf, perl=TRUE) 
  if(!any(length(TITLE))){ 
    recorta<-function(number){ 
      tam<-nchar(number) 
      return(substr(number, 1, tam-1)) 
    } 
    mz2<-recorta(mz) 
    TITLE<-grep(paste(".+MS/MS of ", mz2, ".+ 1\\+ at ", rt, sep=""), in.mgf, perl=TRUE) 
    if(!any(length(TITLE))){ 
      rt2<-recorta(rt) 
      TITLE<-grep(paste(".+MS/MS of ", mz, ".+ 1\\+ at ", rt2, sep=""), in.mgf, perl=TRUE) 
      if(!any(length(TITLE))){ 
        TITLE<-grep(paste(".+MS/MS of ", mz2, ".+ 1\\+ at ", rt2, sep=""), in.mgf, perl=TRUE) 
        if(!any(length(TITLE))){ 
          print(" mz and rt values do not match with any spectra!") 
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          return(NULL) 
        } 
      } 
    } 
  } 
  if(length(TITLE)>1) 
    print(" WARNING: More than one hit matched!") 
  begin.ions<-TITLE-3 
  for (end.ions in (TITLE+3):length(in.mgf)) 
    if(in.mgf[end.ions]=="END IONS") 
      break 
  subset<-in.mgf[begin.ions:end.ions] 




# Function to generate a .mgf file for each of the rows of a 'Ident.*.clustered' table. 
# This requires a directory with the name spectra in the current directory. 
## USAGE: generateMGFs(tabla=Ident.Pv.clustered, sample="Pv", 
pos_mgf="C8_PV_targetedMSMSpos_6and4_3collr1.mgf", 
neg_mgf="C8_PV_targetedMSMSneg_6and4_3collr1.mgf") 
generateMGFs<-function(tabla, sample, pos_mgf, neg_mgf){ 
  tabla<-tabla[order(-tabla$Rev.Dot),] 
  for(i in 1:dim(tabla)[1]){ 
    if(any(grep("pos", tabla[i,3]))){ 
      in.mgf<-pos_mgf 
    out.mgf<-"pos.mgf" 
    } else { 
      in.mgf<-neg_mgf 
      out.mgf<-"neg.mgf" 
    } 
    out.mgf<-paste(sample, i, "_", tabla[i,9], tabla[i,1], out.mgf, sep="") 
    getMGF.feelinglucky(mz=tabla[i,2], rt=tabla[i,5], in.mgf, paste("spectra", out.mgf, sep="/")) 




# Function to identify product ions and neutral loss features from a multi-mgf file 







  write.table(" This is the report for PIS and NLS", report, append=FALSE, col.names=FALSE, 
quote=FALSE, row.names=FALSE) 
  write.table("", report, append=TRUE, col.names=FALSE, quote=FALSE, 
row.names=FALSE) 
  DB<-read.table(DB, header=TRUE, sep="\t", comment.char = "#") 
  forPIS<-DB[which(DB$Mode==mode & DB$msms.scantype=="PIS"),] 
  forNLS<-DB[which(DB$Mode==mode & DB$msms.scantype=="NLS"),] 
  MGF<-readLines(MGF) 
  spectra.beginings<-grep("BEGIN IONS", MGF) 
  spectra.endings<-grep("END IONS", MGF) 
  spectra.num<-length(spectra.beginings) 
  spectra<-vector("list", spectra.num) 
  count<-1 
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  # Separating the spectra 
  for(i in 1:spectra.num){ 
    spectra[[count]]<-MGF[spectra.beginings[i]:spectra.endings[i]] 
    count<-count+1 
  } 
  # Identification by Product Ion Scan 
  withHitsPIS<-unlist(lapply(spectra, function(spectra){ 
    # spectra<-spectra[[5061]] 
    # Obtaining only the m/z values 
    Ions<-spectra[6:(length(spectra)-1)] 
    Ions<-sub("\\\t.+", "", Ions) 
    # Comparing with PIS values from DB 
    positives<-sapply(forPIS$exact.mass, function(mz.db){ 
      return(abs(mz.db-as.numeric(Ions))<=mz.threshold) 
    }) 
    if(sum(positives)>0){ 
      if(sum(rowSums(positives)>1)>0) 
        print(paste(" Something weird happened in the spectra number ", i, sep="")) 
      found<-as.character(forPIS$Lipid.class[which(colSums(positives)>0)]) 
#     forPIS[which(colSums(positives)>0),] 
      return(c(spectra[2], spectra[4], found))  
    } else{ 
      return(NULL) 
    } 
#return(sum(positives)) 
  })) 
  # Identification by Neutral Loss Scan 
  withHitsNLS<-unlist(lapply(spectra, function(spectra){ 
    # spectra<-spectra[[440]] 
    precursor<-as.numeric(sub("PEPMASS=(\\d+\\.\\d+)\\s+", "\\1", spectra[2])) 
    # Obtaining only the m/z values 
    Ions<-spectra[6:(length(spectra)-1)] 
    Ions<-sub("\\\t.+", "", Ions) 
    # Comparing with NLS values from DB 
    positives<-sapply(forNLS$exact.mass, function(mz.db){ 
      return(abs(mz.db-(precursor-as.numeric(Ions)))<=mz.threshold) 
    }) 
    if(sum(positives)>0){ 
      if(sum(rowSums(positives)>1)>0) 
        print(paste(" Something weird happened in the spectra number ", i, sep="")) 
      found<-as.character(forNLS$Lipid.class[which(colSums(positives)>0)]) 
#     forNLS[which(colSums(positives)>0),] 
      return(c(spectra[2], spectra[4], found))  
    } else{ 
      return(NULL) 
    } 
#return(sum(positives)) 
  })) 
 
  # Identifying hits in PIS and NLS regardless if the identification of the Lipid Class was the 
same 
  HitsPIS<-grep("PEPMASS=", withHitsPIS) 
  HitsInPISandNLS<-NULL 
  for(i in HitsPIS) 
  # i<-2 
    if(any(grep(withHitsPIS[i+1], withHitsNLS))) 
      HitsInPISandNLS<-c(HitsInPISandNLS, withHitsPIS[i+1]) 
  write.table(paste(length(HitsInPISandNLS), " where identified in PIS and NLS "), report, 
append=TRUE, col.names=FALSE, quote=FALSE, row.names=FALSE) 





   
  # Clustering the precursors to identify spectra with more than one hit. 
  # Then checking if the assignments were consistent. 
  AllHits<-c(withHitsPIS, withHitsNLS) 
  AllHits.PEPMASS<-grep("PEPMASS=", AllHits) 
  AllHits.num<-length(AllHits.PEPMASS) 
  TheHits<-vector("list", AllHits.num) 
  count<-1 
  for(i in 1:AllHits.num){ 
    if(i!=AllHits.num){ 
      TheHits[[count]]<-AllHits[AllHits.PEPMASS[i]:(AllHits.PEPMASS[i+1]-1)] 
    } else{ 
      TheHits[[count]]<-AllHits[AllHits.PEPMASS[i]:length(AllHits)] 
    } 
    count<-count+1 
  } 
  temp<-unlist(lapply(TheHits, function(x)@x[1]})) # Substitute the @ for a { 
  Precursors<-names(rev(sort(table(temp)))) 
  # Idea: por cada precursor unico ver que asignaciones se encontraron, si son congruentes se 
reporta, si no, se reporta como ambiguo. 
  # The following takes into account the possible multiple hits for the same spectra (same 
precursor, same retention time) 
  for(i in 1:length(Precursors)){ 
# i<-1 
    spectras<-grep(Precursors[i], TheHits) 
    subSpectras<-lapply(spectras, function(x){ 
      return(TheHits[[x]]) 
    }) 
    tabla.assign<-table(unlist(lapply(subSpectras, function(x){ 
      maximo<-length(x) 
      return(x[3:maximo]) 
    }))) 
#  write.table(" This is the report for PIS and NLS", report, append=FALSE, col.names=FALSE, 
quote=FALSE, row.names=FALSE) 
    write.table(Precursors[i], report, append=TRUE, col.names=FALSE, quote=FALSE, 
row.names=FALSE) 
    write.table(tabla.assign, report, append=TRUE, col.names=FALSE, quote=FALSE, 
row.names=FALSE) 
    write.table("", report, append=TRUE, col.names=FALSE, quote=FALSE, 
row.names=FALSE) 
  } 
 
  IdentifiedTwice<-unlist(lapply(TheHits, function(spectra){ 
# spectra<-TheHits[[96]] 
    if(length(spectra)==4){ 
      if(any(grep(spectra[3], spectra[4]))){ 
        return(c(spectra[1], spectra[2], spectra[3])) 
      } else if(any(grep(spectra[4], spectra[3]))){ 
        return(c(spectra[1], spectra[2], spectra[4])) 
      } else { 
        write.table(paste(" Ambiguous identification or double lipid in ", spectra[2], sep=""), 
report, append=TRUE, col.names=FALSE, quote=FALSE, row.names=FALSE) 
        return(NULL) 
      } 
    } else if (length(spectra)==5){ 
      opciones<-c(spectra[3], spectra[4], spectra[5]) 
      if(table(nchar(opciones))>1 & sum(table(opciones)>1)>0){ 
        # At least there are two objects with the same length and are not the same Lipid Class 
        write.table(paste(" Ambiguous identification or double lipid in ", spectra[2], sep=""), 
report, append=TRUE, col.names=FALSE, quote=FALSE, row.names=FALSE)         
        return(NULL) 
      } 
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      primero<-opciones[which.min(nchar(opciones))] 
      tercero<-opciones[which.max(nchar(opciones))] 
      segundo<-opciones[c(-which.min(nchar(opciones)), -which.max(nchar(opciones)))] 
      if(any(grep(primero, segundo)) | any(grep(primero, tercero))){ 
        return(c(spectra[1], spectra[2], primero)) 
      } else if(any(grep(segundo, tercero)) | any(grep(segundo, primero))){ 
        return(c(spectra[1], spectra[2], segundo)) 
      } else if(any(grep(tercero, primero)) | any(grep(tercero, segundo))){ 
          return(c(spectra[1], spectra[2], tercero)) 
      } else { 
        write.table(paste(" Ambiguous identification or double lipid in ", spectra[2], sep=""), 
report, append=TRUE, col.names=FALSE, quote=FALSE, row.names=FALSE) 
        return(NULL) 
      } 
    } 
  })) 
  write.table("", report, append=TRUE, col.names=FALSE, quote=FALSE, 
row.names=FALSE) 
  write.table("Precursors with a second molecule indetification: ", report, append=TRUE, 
col.names=FALSE, quote=FALSE, row.names=FALSE) 
  write.table(IdentifiedTwice, report, append=TRUE, col.names=FALSE, quote=FALSE, 
row.names=FALSE) 
  print(" Done") 


























List of m/z values used to perform the Tandem MS experiment 
 












Candidamtes from the P. vivax-infected samples in negative mode. 
 
 
Candidates from the non-infected samples in positive mode. 
 
Candidates from the non-infected samples in negative mode. 
 
 
